<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Malar J</journal-id><journal-id journal-id-type="iso-abbrev">Malar. J</journal-id><journal-id journal-id-type="pmc-domain-id">98</journal-id><journal-id journal-id-type="pmc-domain">malarj</journal-id><journal-title-group><journal-title>Malaria Journal</journal-title></journal-title-group><issn pub-type="epub">1475-2875</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4758146</article-id><article-id pub-id-type="pmcid-ver">PMC4758146.1</article-id><article-id pub-id-type="pmcaid">4758146</article-id><article-id pub-id-type="pmcaiid">4758146</article-id><article-id pub-id-type="pmid">26888537</article-id><article-id pub-id-type="doi">10.1186/s12936-016-1163-3</article-id><article-id pub-id-type="publisher-id">1163</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Transmission-blocking strategies: the roadmap from laboratory bench to the community</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Gon&#231;alves</surname><given-names initials="D">Daniel</given-names></name><address><email>daniel.goncalves@unibas.ch</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hunziker</surname><given-names initials="P">Patrick</given-names></name><address><email>hunzikerp@swissnano.org</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">CLINAM Foundation for Nanomedicine, University of Basel, Basel, Switzerland </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">262781</issue-id><elocation-id>95</elocation-id><history><date date-type="received"><day>5</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>11</day><month>2</month><year>2016</year></date></history><pub-history><event event-type="pmc-release"><date><day>18</day><month>02</month><year>2016</year></date></event><event event-type="pmc-live"><date><day>19</day><month>02</month><year>2016</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-18 00:25:10.563"><day>18</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; Gon&#231;alves and Hunziker. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12936_2016_Article_1163.pdf"/><abstract id="Abs1"><p>Malaria remains one of the most prevalent tropical and infectious diseases in the world, with an estimated more than 200 million clinical cases every year. In recent years, the mosquito stages of the parasite life cycle have received renewed attention with some progress being made in the development of transmission-blocking strategies. From gametocytes to late ookinetes, some attractive antigenic targets have been found and tested in order to develop a transmission blocking vaccine, and drugs are being currently screened for gametocytocidal activity, and also some new and less conventional approaches are drawing increased attention, such as genetically modified and fungus-infected mosquitoes that become refractory to <italic toggle="yes">Plasmodium</italic> infection. In this review some of those strategies focusing on the progress made so far will be summarized, but also, the challenges that come from the translation of early promising benchwork resulting in successful applications in the field. To do this, the available literature will be screened and all the pieces of the puzzle must be combined: from molecular biology to epidemiologic and clinical data.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Transmission blocking strategies</kwd><kwd>Refractory mosquitoes</kwd><kwd>Gametocytocidal drugs</kwd><kwd>Malaria vaccine</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerische Nationalfonds zur F&#246;rderung der Wissenschaftlichen Forschung (CH)</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution>SNI - Swiss Nanoscience Institut</institution></funding-source><award-id>P1306</award-id><principal-award-recipient><name name-style="western"><surname>Gon&#231;alves</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><sec id="Sec2"><title>Why block transmission?</title><p>Malaria remains one of the most prevalent tropical and infectious diseases in the world, both, in terms of morbidity and mortality, with around 200 million cases estimated in 2013 alone [<xref ref-type="bibr" rid="CR1">1</xref>]. Four different species consistently infect humans: <italic toggle="yes">Plasmodium</italic><italic toggle="yes">falciparum</italic>, <italic toggle="yes">Plasmodium</italic><italic toggle="yes">vivax</italic>, <italic toggle="yes">Plasmodium</italic><italic toggle="yes">malariae</italic>, and <italic toggle="yes">Plasmodium</italic><italic toggle="yes">ovale</italic>. From these, <italic toggle="yes">P.</italic><italic toggle="yes">falciparum</italic> and <italic toggle="yes">P.</italic><italic toggle="yes">vivax</italic> are the most common with the former being by far the most lethal [<xref ref-type="bibr" rid="CR2">2</xref>&#8211;<xref ref-type="bibr" rid="CR5">5</xref>]. Recently, different accounts of human malaria by another species, <italic toggle="yes">Plasmodium knowlesi</italic>, which usually infects macaque monkeys, have been reported in Southeast Asia [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p>Since the beginning of the twenty-first Century there has been renewed attention towards the disease, and in 2007 an official research and development agenda for malaria eradication (malERA) was established [<xref ref-type="bibr" rid="CR7">7</xref>]. The goal is to completely eliminate and, if possible, eradicate the disease from as many areas as possible and control the others. The main strategies being followed include: the increase of insecticidal nets reach, especially long-lasting insecticidal nets (LLINs), within affected communities; use of artemisinin-based combination therapy (ACT) as first-line treatment; and, support the development of a vaccine, with RTS,S/Mosquirix the first being made available and recently approved by the European Medicines Agency (EMA) for children aged 6&#160;weeks to 17&#160;months (exclusively against <italic toggle="yes">P. falciparum</italic>) [<xref ref-type="bibr" rid="CR8">8</xref>]. Data from 2013 showed that since the beginning of the programme the malaria mortality rate decreased 26&#160;%, even with an increase of 43&#160;% in population living in transmission areas [<xref ref-type="bibr" rid="CR1">1</xref>]. In the 2015 report, WHO estimates that malaria control interventions averted a total of 663 million malaria cases between 2001 and 2015 in sub-Saharan Africa, which 69&#160;% are accounted to the use of insecticide-treated mosquito nets (ITNs), 21&#160;% due to ACT and 10&#160;% due to indoor residual spraying (IRS) [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p>While these numbers may be interpreted as progress towards winning this war, recent findings revealed some worrying indicators that <italic toggle="yes">Plasmodium</italic> is fighting back. Artemisinin and its derivatives are considered the current last line of defence and have been used in combination with other anti-malarials to avoid resistance development, but artemisinin-resistant strains of <italic toggle="yes">P. falciparum</italic> have appeared in Southeast Asia with strong indications of rapid spread [<xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR16">16</xref>]. Another worrying indicator is <italic toggle="yes">Anopheles gambiae</italic> (the predominant vector in Africa) resistance to pyrethroids in various sub-Saharan regions [<xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR20">20</xref>]. The combined proportion of affected population in sub-Saharan Africa with access to IRS and ITNs increased from 2&#160;% in 2000 to 59&#160;% in 2014 [<xref ref-type="bibr" rid="CR9">9</xref>], and is responsible for reducing child deaths by an average 18&#160;% [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], but also for spreading pyrethroid resistance. There are four different classes that can be used in IRS, but only pyrethroids are currently recommended for LLINs [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p><p>In recent years, there has been wider interest in mosquito stages as potential targets for new transmission-blocking strategies (TBS) that could help to control, and ultimately, eliminate the disease. New TBS being studied differ mainly from the classical vector control approaches, such as the use of insecticides, because they are designed for mosquito survival, thus avoiding selective pressure towards resistance [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Two of the major metrics for malaria transmission intensity are: the basic reproductive number (R<sub>0</sub>) representing the number of new cases deriving from one untreated case in an infinite and susceptible human population; and, the entomological inoculation rate (EIR) that measures the rate of <italic toggle="yes">Plasmodium</italic>-infected mosquito bites per person, per year [<xref ref-type="bibr" rid="CR25">25</xref>]. Both are of extreme relevance to TBS, not only to provide insights on the impact, but also to set &#8216;critical numbers&#8217; as goals for a successful strategy [<xref ref-type="bibr" rid="CR26">26</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>]. Mathematical modelling based on available field data shows that it should be enough to reduce transmission to R<sub>0</sub>&#160;&lt;&#160;1 for a certain period of time to irreversibly compromise the sustainability of the disease [<xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref>]. In addition, because malaria transmission is a local feature with the source of infection (breeding site) located within a maximum of a 1-km perimeter [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], TBS are particularly suited to circumscribe small pockets of malaria in isolated communities.</p><p>There are three main TBS that are being pursued: gametocytocidal drugs, transmission-blocking vaccines and shifting mosquitoes towards refractory traits. Each of these will be briefly reviewed and a short outlook will present bench progress and challenges, especially large-scale implementation and ethical issues, referenced, when possible, with clinical, entomological and field data.</p></sec><sec id="Sec3"><title><italic toggle="yes">Plasmodium</italic> life cycle</title><p>Due to the apicomplexan nature of the <italic toggle="yes">Plasmodium</italic> life cycle which allows it to survive in different environments, the parasites are well adapted to their obligatory hosts: a vertebrate and the female of the <italic toggle="yes">Anopheles</italic> genus [<xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR39">39</xref>].</p><p>In humans, the first target of the parasites are the liver cells (hepatocytes), until the point they are released into the blood stream to invade red blood cells in the form of merozoites; it is estimated that each sporozoite that enters the body originates approximately 1000 erythrocyte-infective parasites [<xref ref-type="bibr" rid="CR40">40</xref>]. Once inside, they reproduce asexually in a (48-h cycle for falciparum) while also forming agglomerates of infected cells to avoid spleen clearance [<xref ref-type="bibr" rid="CR41">41</xref>]. Eventually, some of the merozoites develop into gametocytes, the sexual form of the parasite, maturing inside the parasitophorous vacuole until released to the peripheral blood, waiting for another mosquito bite to propagate the disease [<xref ref-type="bibr" rid="CR42">42</xref>]. Parasitaemia in symptomatic infected humans can range from 100 to more than 250,000 parasites per &#181;l of blood (hyperparasitaemia) [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>].</p><p>When a female <italic toggle="yes">Anopheles</italic> mosquito bites an infected vertebrate host, it results in the ingestion of a certain number of gametocytes. Within 15&#160;min, the midgut lumen environment triggers the gametocyte egress and differentiation into micro and macrogametes [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. The following fusion leads to diploid cells (zygote) that will undergo meiotic division resulting in motile ookinetes [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. The main goal of ookinetes is to physically traverse a thick (1&#8211;20&#160;&#181;m) chitin-based peritrophic membrane (PM) formed upon blood ingestion, and the midgut epithelium [<xref ref-type="bibr" rid="CR47">47</xref>&#8211;<xref ref-type="bibr" rid="CR49">49</xref>]. The midgut invasion is not pacific and leads to apoptosis of the invaded cells [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. After establishing itself at its basal side, a few parasites (less than ten in average) will develop into the oocyst form, concluding one of the most critical stages in whole life cycle (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>].<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Representation of the malaria life cycle. <italic toggle="yes">Arrows</italic> represent the different stages of infection and parasite density, in humans: <italic toggle="yes">1</italic> invasion of hepatocytes, <italic toggle="yes">2</italic> merozoites maturation and release, <italic toggle="yes">3a</italic> intra-erythrocytic cycle, <italic toggle="yes">3b</italic> gametocytes formation; and, mosquito: <italic toggle="yes">1</italic> gametes egress and fertilization, <italic toggle="yes">2</italic> meiotic division and midgut invasion, <italic toggle="yes">3</italic> oocyst fixation and mitotic division, <italic toggle="yes">4</italic> sporozoites release and salivary glands invasion</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12936_2016_1163_Fig1_HTML.jpg"/></fig></p><p>Mitotic divisions start occurring at this stage and ultimately sporozoites are formed. Upon egress from mature oocysts, sporozoites travel via the haemolymph and can be found throughout the mosquito haemocoel until some of them reach the salivary glands [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Less than 20&#160;% of the sporozoites entering the haemocoel will establish themselves in the salivary gland with the remaining being eliminated [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p>Transmission of sporozoites occurs when the mosquito ejects saliva into the skin, probing for a blood vessel. Despite some mosquitoes can harbour as many as thousands of sporozoites in their salivary glands, only a small number (10&#8211;200) are ejected from the salivary ducts [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. After their injection into the dermis, they will try to find and invade a hepatocyte as soon as possible before detection of the immune system and continue the cycle [<xref ref-type="bibr" rid="CR55">55</xref>].</p><p>In summary, the main differences between the mosquito and humans stages are:<list list-type="bullet"><list-item><p>the mosquito the parasites are exclusively extracellular;</p></list-item><list-item><p>there are, on average, fewer parasites in the vector comparing to the human host (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>);</p></list-item><list-item><p>there are no antibodies produced against <italic toggle="yes">Plasmodium</italic> in the mosquito despite other mechanisms are available to detect and eliminate the parasites [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>];</p></list-item><list-item><p>morphology and proteome of <italic toggle="yes">Plasmodium</italic> differ completely from stage to stage, and the only common cells between hosts (excluding the short period of gametocytes in the mosquito) are the sporozoites [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>];</p></list-item><list-item><p>mosquito infection is not lethal <italic toggle="yes">per se</italic> but can be a metabolic and cellular burden, especially during the midgut crossing stage. If this comes with a fitness cost to the mosquitoes in the field is still not clear, with contradictory claims in the literature [<xref ref-type="bibr" rid="CR60">60</xref>&#8211;<xref ref-type="bibr" rid="CR62">62</xref>].</p></list-item></list></p></sec><sec id="Sec4"><title>Gametocyte density and prevalence</title><p>The proportion of merozoites committed to sexual development and the exact mechanism (including sex ratio determination) are not yet fully understood [<xref ref-type="bibr" rid="CR63">63</xref>&#8211;<xref ref-type="bibr" rid="CR70">70</xref>]. Gametocytogenesis differs between <italic toggle="yes">Plasmodium</italic> species: while all of them undergo a five-stage maturation process (with some morphological differences), falciparum gametocytes, for example, take the longest (10&#8211;12&#160;days as opposed to less than 48&#160;h for the majority) and are not produced simultaneously with the asexual stages. Mature gametocytes persistence in the peripheral blood is estimated to be lower in <italic toggle="yes">P. vivax</italic> (approximately 3&#160;days) than in <italic toggle="yes">P.</italic><italic toggle="yes">falciparum</italic> (3.4&#8211;6.5&#160;days) [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR70">70</xref>&#8211;<xref ref-type="bibr" rid="CR72">72</xref>].</p><p>High circulating gametocyte numbers do not necessarily result in mosquito infection, and low gametocyte densities do not exclude infectivity; a self-regulated or host-induced response (fever, antibodies, cytokines) still remains unclear [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Even so, evidence suggests that transmission success is highly dependent on the proportion of mature gametocytes [<xref ref-type="bibr" rid="CR75">75</xref>].</p><p>Despite all the data available on gametocyte prevalence and density, measuring gametocytaemia levels reliably is still a challenge. The rule of thumb is that the gametocyte count by microscopy techniques usually underestimates the true number by more than 50&#160;% [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. More sensitive molecular methods such as quantitative nucleic acid sequence-based amplification (QT-NASBA), reverse transcriptase PCR (RT-PCR) and RT loop-mediated isothermal amplification (RT-LAMP) have been developed [<xref ref-type="bibr" rid="CR77">77</xref>&#8211;<xref ref-type="bibr" rid="CR79">79</xref>]. Despite their usefulness, there is the obvious cost and training barriers for applying any of these technologies in the field when the available resources, both human and capital, are already scarce. Thus, a thorough analysis from local authorities and health policy makers to invest in the right resources should be made, being it microscopy, rapid diagnosis tests (RDT) or more advanced molecular biology tools (or a combination of all), resulting in a clear diagnosis strategy defined according to: epidemiological settings of prevalence and density; the health impact of the disease using metrics like the disability-adjusted life year (DALY) in the local population; and economical, not only immediate, such as throughput and cost per unit/case and treatment costs avoided, but also long term, factoring the costs of morbidity and mortality in the socioeconomic advancement of the affected society [<xref ref-type="bibr" rid="CR80">80</xref>&#8211;<xref ref-type="bibr" rid="CR83">83</xref>].</p><p>Various studies have also attempted to estimate the relative contribution to mosquito infection of different patient age groups [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR84">84</xref>&#8211;<xref ref-type="bibr" rid="CR88">88</xref>]. Despite some evident differences in gametocyte density and prevalence between adults and children, the data are not conclusive and are hard to compare due to lack of consistency in gametocytes estimation methods but also in infection models (skin or membrane feeding assays) [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]. The non-linear relation, especially at low densities, between human parasitaemia and mosquito infectiousness, and differences in the endemic settings further enhances the challenge in drawing conclusions from these studies. A thorough understanding of the factors determining transmission would not only allow mathematical models to predict the relative contribution of different groups to transmission, but also help to find the most efficient way to implement a TBS and measure its impact.</p></sec><sec id="Sec5"><title>Transmission-blocking strategies</title><sec id="Sec6"><title>Gametocytocidal drugs</title><p>One of the first approaches to be explored was the gametocytocidal activity of commercially available anti-malarial drugs [<xref ref-type="bibr" rid="CR90">90</xref>]. The rationale was to block transmission by clearing most gametocytes in the human host to render those patients non-infectious to mosquitoes. ACT (artemisinin-piperaquine) combined with a low dose of primaquine (PQ) has been used to help eliminate malaria from 17 Cambodian villages [<xref ref-type="bibr" rid="CR91">91</xref>], although it is hard to make a clear distinction between the direct effect on gametocytes clearance and the indirect one of ACT reducing the numbers of asexual parasites that could develop into gametocytes [<xref ref-type="bibr" rid="CR92">92</xref>]. Nevertheless, recognizing the importance of reducing transmission, in 2010 WHO recommended a single dose of PQ of 0.75&#160;mg/kg as a gametocytocidal agent (not sufficient for hypnozoite clearance in <italic toggle="yes">P. vivax</italic> infections), in combination with ACT making it the first TBS to be endorsed for field application. However, this dose level has restrictions as it should not be given to pregnant women or small children and because there is the risk of haemolysis in people affected with glucose-6-phosphate dehydrogenase (G6PD) deficiency, although it most be said that the deficiency is originated from different variants that translate into different phenotypes (from mild to severe) that must be accounted when determining PQ safety in such patients [<xref ref-type="bibr" rid="CR93">93</xref>&#8211;<xref ref-type="bibr" rid="CR95">95</xref>]. Finally, in 2012, WHO revised their recommendation to 0.25&#160;mg/kg in a single dose, but this is still not advised for pregnant women and infants [<xref ref-type="bibr" rid="CR96">96</xref>].</p><p>Responsiveness to drugs is something difficult to compare between <italic toggle="yes">Plasmodium</italic> species. For <italic toggle="yes">P. vivax</italic> only a few clinical data are available because continuous ex vivo culture methods are not yet ready to screen drugs for gametocytocidal activity [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR97">97</xref>&#8211;<xref ref-type="bibr" rid="CR102">102</xref>]. Even with in vitro culture, where different protocols of sexual stages of <italic toggle="yes">P. falciparum</italic> from gametocytes to ookinetes have been recently made available [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>], a relevant limitation in screening anti-malarials and new molecular entities (NMEs) for gametocytocidal activity is the throughput of such models. It certainly opened the door for a wide variety of drugs to be tested using different methods such as ATP bioluminescence, confocal fluorescence and AlarmBlue oxireduction [<xref ref-type="bibr" rid="CR105">105</xref>&#8211;<xref ref-type="bibr" rid="CR109">109</xref>], but the variability between activity measurements of the same drug, sometimes even with the same method (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>), and the lack of a true high-throughput model that is able to screen more than 1000 molecules at a time to effectively search for leads and new scaffolds to design the best drugs for these stages, indicates there is still a lot of progress to be made. There have been some efforts and advances in this direction [<xref ref-type="bibr" rid="CR110">110</xref>&#8211;<xref ref-type="bibr" rid="CR112">112</xref>] but still far from the standard screening models available for asexual stages [<xref ref-type="bibr" rid="CR113">113</xref>].<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Comparison of in vitro gametocytocidal activities with different methods and anti-malarial drugs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Drug</th><th align="left" colspan="1" rowspan="1">IC50 uM (stage IV&#8211;V)</th><th align="left" colspan="1" rowspan="1">Method</th><th align="left" colspan="1" rowspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Primaquine</td><td align="left" colspan="1" rowspan="1">&gt;10</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">7.2</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1">Mefloquine</td><td align="left" colspan="1" rowspan="1">100</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">4.7</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1">Pyronaridine</td><td align="left" colspan="1" rowspan="1">4.260</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">3.2</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">0.28</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1">Pentamidine</td><td align="left" colspan="1" rowspan="1">0.404</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">2.85</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1">Methylene Blue</td><td align="left" colspan="1" rowspan="1">0.287</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">0.49</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">0.012</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td align="left" rowspan="2" colspan="1">Diihydroartemisin</td><td align="left" colspan="1" rowspan="1">0.00217</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">3.56</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1">Artesunate</td><td align="left" colspan="1" rowspan="1">2.53</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">2.3</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">10.48</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td align="left" rowspan="3" colspan="1">Epoximicin</td><td align="left" colspan="1" rowspan="1">0.00042</td><td align="left" colspan="1" rowspan="1">ATP bioluminescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">0.0014</td><td align="left" colspan="1" rowspan="1">Alamar Blue</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR108">108</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">0.00066</td><td align="left" colspan="1" rowspan="1">HTS confocal fluorescence</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr></tbody></table></table-wrap></p><p>Most of the research is focused on the late gametocyte stage but it is also possible to target the mosquito stages of the parasites (sporontocidal activity), as demonstrated with proguanil, pyrimethamine and most endoperoxides [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR105">105</xref>]. The rate and timing at which gametocytes are cleared or neutralized (transmission time-window) is a factor to take into account when considering a transmission blocking drug, for example a single dose of PQ that has very short-live and targets only late gametocytes, may leave a certain number of gametocytes behind that will eventually mature and able to infect mosquitoes [<xref ref-type="bibr" rid="CR114">114</xref>&#8211;<xref ref-type="bibr" rid="CR116">116</xref>]. This would not be the case if used in combination with a sporontocidal drug, but on the other hand the long half-life needed to be effective, is a major challenge to overcome.</p><p>A theoretical model recently raised concern by predicting a negative impact on drug resistance for gametocytocidal campaigns, by potentially reducing the transmission of drug-sensitive sexual forms to a greater extent than the drug-resistant ones [<xref ref-type="bibr" rid="CR117">117</xref>]. Despite the fact that some data suggest resistance is spreading faster at both ends of the transmission-intensity spectrum [<xref ref-type="bibr" rid="CR117">117</xref>&#8211;<xref ref-type="bibr" rid="CR120">120</xref>], this possibility has not been conclusively confirmed or refuted by empirical data and, probably, the implications for superinfection (simultaneous infection with multiple genetically distinct parasites) should also be accounted [<xref ref-type="bibr" rid="CR121">121</xref>].</p><p>Another model suggested that increasing ACT coverage would outperform the addition of any specific gametocytocidal drug in reducing transmission [<xref ref-type="bibr" rid="CR122">122</xref>], but even if true, the spreading of artemisinin resistance and PQ side effects should suffice for investing time and resources in the development of a novel, efficacious, late-gametocyte/gamete inhibitor.</p></sec></sec><sec id="Sec7"><title>Transmission-blocking vaccine</title><p>During 2013, the Malaria Vaccine Initiative (MVI) updated its roadmap and included the development of vaccines interrupting malaria parasite transmission (VIMTs) as one of its strategic goals for the next years [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]. The vaccine approach aims to achieve transmission reduction through an immunological attack on sexual or mosquito stages of the life cycle. To this end, an immune response in the human host directed to stage-specific targets is required.</p><p>Surface proteins of gametocytes and gametes (Pfs 2400, Pfs 230, Pfs 48/45, Pfg 27), zygote and ookinete stages (Ps 25, Ps 28) have been the principal candidates [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR125">125</xref>&#8211;<xref ref-type="bibr" rid="CR128">128</xref>], but other epitopes from later stages (Ps 21), molecules such as chitinase, which is important for PM and midgut traversal, and alanyl aminopeptidase (AnAPN1), an antigen in the midgut surface, important for ookinete recognition, were identified as potential targets [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. Since there is a population chokepoint occurring, the appeal, in terms of resistance spread and elimination purposes, of targeting later stages in the mosquito infection is obvious, even if the quantitative translation of reducing parasite numbers in different stages into a successful transmission and propagation of malaria is not well enough understood [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR131">131</xref>].</p><p>To develop a successful vaccine, choosing the best target is just the first step, and the need to find a good production and delivery system, complemented by an appropriate formulation and potential adjuvants, is also important [<xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]. Apart from killed or attenuated whole pathogens (non-practical for mosquito stages) [<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR135">135</xref>], large-scale production of protein antigens is doable using various recent technologies, either synthetic or recombinant, but correct folding, a prerequisite for achieving highly specific high titres in humans is still a challenge [<xref ref-type="bibr" rid="CR136">136</xref>&#8211;<xref ref-type="bibr" rid="CR138">138</xref>]. In the case of malaria and transmission-blocking vaccines (TBVs) in particular, several expression systems for recombinant antigens have been used, including <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Lactococcus lactis</italic> bacterium models, <italic toggle="yes">Baculovirus</italic>, yeast (<italic toggle="yes">Pichia pastoris, Saccharomyces cerevisae)</italic>, plant-based systems, and algae [<xref ref-type="bibr" rid="CR138">138</xref>&#8211;<xref ref-type="bibr" rid="CR144">144</xref>]. Particle-delivery technology, such as virus-like particles (VLP) and nanoparticles, are also being pursued [<xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR145">145</xref>], and the recently developed DNA vaccine technology has been tried but it is still in a very early stage of development [<xref ref-type="bibr" rid="CR146">146</xref>&#8211;<xref ref-type="bibr" rid="CR148">148</xref>].</p><p>Some candidates using different antigens, production and delivery strategies are currently in preclinical stage and being considered for the first tests in humans [<xref ref-type="bibr" rid="CR149">149</xref>], and others, such as AnAPN1, are still at earlier stage but nevertheless promising because the antibodies produced appear to inhibit both <italic toggle="yes">P. falciparum</italic> and <italic toggle="yes">P. vivax</italic> [<xref ref-type="bibr" rid="CR129">129</xref>]. Targeting <italic toggle="yes">P. vivax</italic> is of particular importance since this parasite can stay undetected in the liver in the hypnozoite dormant over 2&#160;years, with PQ being the only medicine to target them at the moment [<xref ref-type="bibr" rid="CR150">150</xref>]. Two different recombinant strategies (using virus-like and conjugating with <italic toggle="yes">Pseudomonas aeruginosa</italic> exoprotein A) targeting Pfs25 antigen are already in phase I of clinical trials [<xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>], and are the first official candidates for VIMTs targeting sexual, sporogonic or mosquito-stage antigens (SSM-VIMT) but are still a small fraction of the malaria vaccine pipeline [<xref ref-type="bibr" rid="CR153">153</xref>].</p><p>In addition to the development of a stand-alone SSM-VIMT, which would not confer immediate benefit to a vaccine recipient, a vaccine targeting both SSM and other stage-malaria antigens is being studied. Examples of such an approach are the fusion of circumsporozoite protein (CSP), Pfs 25 and glutamate-rich protein (GLURP) with Pfs 48/45 [<xref ref-type="bibr" rid="CR154">154</xref>&#8211;<xref ref-type="bibr" rid="CR156">156</xref>]. Just as targeting antigens from multiple parasite stages may create synergies, the use of a vaccine and drug together could also maximize the impact on transmission for a longer period than a drug alone could. It was also suggested that a SSM-VIMT could be coformulated or co-administrated with another health intervention (as Mosquirix with hepatitis B) that targets the same population to render it directly beneficial to recipients, and overcome some of the ethical issues associated with this kind of intervention [<xref ref-type="bibr" rid="CR157">157</xref>, <xref ref-type="bibr" rid="CR158">158</xref>].</p></sec><sec id="Sec8"><title>Refractory mosquitoes</title><p>Mosquitoes have their own natural mechanisms to fight <italic toggle="yes">Plasmodium</italic>, with a small percentage of them being refractory to the infection [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Researchers have recently started to explore possible ways to exploit this observation in the malaria elimination effort. The idea is to (naturally or artificially) emulate the refractoriness processes in the laboratory and somehow introduce it in the field, in such a way that will eventually shift the mosquito population towards a <italic toggle="yes">Plasmodium</italic>-resistant vector phenotype. Some of the strategies were borrowed from other vectors and disease control programmes and are already tested in the field on a small scale, and others still are in an early stage of research [<xref ref-type="bibr" rid="CR158">158</xref>&#8211;<xref ref-type="bibr" rid="CR161">161</xref>]. They fall into three categories: population replacement, artificial gene drive mechanisms and third-party modified organisms as delivery systems. Their common feature is the expression of at least one effector molecule responsible for malaria refractoriness. Since this requisite is not met with population suppression methods, such as the release of insects carrying a dominant lethal genetic systems (RIDL), it is not included in this topic.</p><p>An ideal effector molecule will not convey a fitness cost to the insect host and could be used in combination to target different stages of the parasite development. Some candidates already tested include phospholipase A2 (PLA2), shown to inhibit ookinete invasion through an unknown mode of action [<xref ref-type="bibr" rid="CR162">162</xref>], and salivary gland and midgut peptide 1 (SM1) that is thought to block recognition sites for sporozoites and ookinetes [<xref ref-type="bibr" rid="CR163">163</xref>].</p><p>Population replacement can be achieved by releasing either genetically modified (GM) mosquitoes that express a killing or disabling agent for the malaria parasites [<xref ref-type="bibr" rid="CR164">164</xref>], or naturally refractory mosquitoes previously selected and reared in the laboratory [<xref ref-type="bibr" rid="CR162">162</xref>]. For large-scale implementation in the field, mosquito releases would probably need to be preceded with intensive insect elimination campaigns to reduce the native population. Release should be done in a controlled manner backed up with a mathematical model giving insight for the stage, numbers, timing, and location that would maximize the desired genetic shifting of the population [<xref ref-type="bibr" rid="CR165">165</xref>]. Even if the fitness cost of the desired trait is designed to be minimal, it is very likely that this shifting will not be incremental and self-sustainable, and in order to maintain the modifications, periodic releases of additional insects might be needed [<xref ref-type="bibr" rid="CR161">161</xref>]. Not only is it difficult and costly to rear such large numbers of mosquitoes to have a meaningful impact on levels of transmission of the disease, there is also the ethical issue behind releasing biting female <italic toggle="yes">Anopheles</italic>, and before being implemented, a careful sensibilization campaign should be made within affected communities.</p><p>As an alternative strategy, gene drive mechanisms have been explored to reduce the number of insects needed (males only) to propagate in a self-sustainable manner without additional releases [<xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR164">164</xref>]. Many solutions have been studied, starting from transposable elements that will be integrated randomly across the genome, or &#8216;selfish genes&#8217;, such as the homing endonuclease genes (HEGs) that are transmitted horizontally within a population by using the host cell DNA repair machinery. The linkage between the drive mechanism and the refractory system deserves special attention and must be engineered in a way that, in case it is broken, there is a safety system to prevent modified insects overtaking the population [<xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR164">164</xref>]. A system consisting of synthetic genetic elements, with mosquito regulatory regions and the HEG I-SceI11-13, has already been demonstrated to substantially increase its transmission to the progeny of <italic toggle="yes">An. gambiae</italic> [<xref ref-type="bibr" rid="CR166">166</xref>], and very recently a Cas9-mediated gene drive mechanism was published with very interesting results [<xref ref-type="bibr" rid="CR167">167</xref>&#8211;<xref ref-type="bibr" rid="CR169">169</xref>].</p><p>Finally, life organisms, such as bacteria and fungi [<xref ref-type="bibr" rid="CR170">170</xref>&#8211;<xref ref-type="bibr" rid="CR172">172</xref>], and even viruses [<xref ref-type="bibr" rid="CR173">173</xref>], have been proposed to be engineered as expressing systems for refractory genes inside the mosquitoes. The diversity of the midgut flora in adult <italic toggle="yes">Anopheles</italic> is well known and includes <italic toggle="yes">Escherichia, Alcaligenes, Pseudomonas, Serratia</italic>, and <italic toggle="yes">Bacillus</italic>, which could be used as paratransgenesis vehicles [<xref ref-type="bibr" rid="CR174">174</xref>]. One such system has been demonstrated with <italic toggle="yes">Escherichia coli</italic> expressing a fusion protein of ricin and a single-chain antibody against Pbs2, inhibiting oocyst formation by 95&#160;% in <italic toggle="yes">Anopheles stephensi</italic> [<xref ref-type="bibr" rid="CR175">175</xref>]. The bacterium <italic toggle="yes">Wolbachia</italic> is a special case that has received much attention lately, as it was observed that infected <italic toggle="yes">Anopheles</italic> became refractory to malaria to a significant extent without the need of further genetic manipulation, although the detailed molecular mechanisms are still unclear<italic toggle="yes">. Wolbachia</italic> inserts a drive mechanism through cytoplasmic incompatibility, meaning that only when both female and male are infected, the fertilized eggs will hatch normally and the bacteria is transovarially transmitted to the next generation [<xref ref-type="bibr" rid="CR160">160</xref>, <xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR176">176</xref>]. Another possibility is the use of entomopathogenic fungi: fungal spores may be extremely robust and have the advantage to infect mosquitoes directly via the cuticle. Fungal spores can be integrated into a number of delivery systems, such as indoor spraying or odour-baited traps [<xref ref-type="bibr" rid="CR159">159</xref>, <xref ref-type="bibr" rid="CR177">177</xref>, <xref ref-type="bibr" rid="CR178">178</xref>]. One such example is <italic toggle="yes">Metarhizium anisopliae</italic>, modified to express a fusion protein between SM1 and scorpine (antimicrobial toxin), which was able to reduce <italic toggle="yes">P. falciparum</italic> sporozoite counts by 98&#160;% in <italic toggle="yes">An. gambiae</italic> [<xref ref-type="bibr" rid="CR178">178</xref>].</p></sec><sec id="Sec9"><title>Future perspectives</title><p>A successful wide-scale implementation of TBS for malaria elimination campaigns is still some way in the future. Each strategy has its own unique challenges but there are some common questions and technical limitations that need to be overcome and answered. One of the central questions in TBS research is the quantitative and qualitative relationship between transmission reduction and its impact in the parasite reservoir. Several studies have been made [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR84">84</xref>&#8211;<xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR131">131</xref>], but there is still a huge knowledge gap to be filled. Better data are needed for human-to-mosquito (and vice versa) transmission rates, prevalence and density of different mosquito stages, and the relation with geographic and demographics (both human and mosquito). The current limited availability of such data is both a challenge and an avenue for further research to translate TBS from the laboratory bench to the field.</p><p>Testing the efficacy of a future transmission-blocking drug or vaccine is a further important requirement. Randomized cluster approaches can be used but the endpoints to assess the clinical relevance of such therapeutics are still not clear [<xref ref-type="bibr" rid="CR137">137</xref>, <xref ref-type="bibr" rid="CR157">157</xref>, <xref ref-type="bibr" rid="CR179">179</xref>]. The ideal endpoint should be the reduction of new human infections from the same epidemiological source following the introduction of the intervention, but is very difficult to achieve in the field. An alternative is to measure the reduction in the total number of cases, but then it is impossible to assess the direct contribution of the treatment. Whichever endpoint is chosen, the real world will require a compromise between directly quantifiable impact and epidemiological relevance.</p><p>A major concern of TBS is regulatory approval, because a clinical development plan for TBS will certainly be different from those applied to other malaria vaccines and drugs. Encouraged by the US Food and Drug Administration (FDA) which clearly states that there is no legal opposition to licensing, and in view of the momentum of new SSM-TBV projects reaching clinical testing, a work group of international experts was established to assess the requirements of an eventual SSM-VIMT Phase III trial [<xref ref-type="bibr" rid="CR179">179</xref>]. One of the conclusions highlighted the critical importance of identifying the minimally required efficacy (and coverage) and the need for specific criteria that will inform early clinical decision-making.</p><p>Both, compartmental and mechanistic mathematical modelling, are paramount for the progress of any of the strategies discussed above [<xref ref-type="bibr" rid="CR180">180</xref>&#8211;<xref ref-type="bibr" rid="CR182">182</xref>]. This was also one of the lessons learned during the previous Global Malaria Eradication Programme (GMEP) during the 1950s and 1960s, where dichlorodiphenyltrichloroethane (DDT) was widely used as insecticide until the programme was discontinued due to a combination of resistance, financial constraints and negative environmental impact [<xref ref-type="bibr" rid="CR183">183</xref>]. Some studies suggest that despite the immediate successes of the programme in certain regions, in others, the gain was lost with resurgence appearing in endemic proportions [<xref ref-type="bibr" rid="CR184">184</xref>]. Thus, the aim should be a long-term strategy, able to measure and predict its impact locally in a specific set of conditions. This will then allow informed decisions on how, where, and when is the best way to implement a certain TBS, and good models and data are crucial to reach that goal [<xref ref-type="bibr" rid="CR185">185</xref>, <xref ref-type="bibr" rid="CR186">186</xref>].</p><p>Even if all these challenges are overcome, the cost-benefit issue remains. Being a disease that targets mainly populations of underdeveloped countries, cost is always a primary challenge for any type of intervention [<xref ref-type="bibr" rid="CR187">187</xref>]. Not only the benefit should be proven, but the cost-per-unit should be optimized to make it affordable for mass campaigns. Logistics is another constraint usually associated with malaria since most affected populations live in very remote regions. A positive indicator came from a recently developed vaccine against meningitis (MenAfriVac<sup>&#174;</sup>), costing less than US$0.50 per dose and able to be removed from constant refrigeration, making it more accessible for handling in remote areas of sub-Saharan Africa [<xref ref-type="bibr" rid="CR157">157</xref>, <xref ref-type="bibr" rid="CR188">188</xref>]. Such features would be highly desirable for a malaria vaccine, but the central question still remains: is it really worth allocating that many resources to develop and implement TBV campaigns in less than optimal efficacy and coverage conditions as seen with Mosquirix [<xref ref-type="bibr" rid="CR189">189</xref>, <xref ref-type="bibr" rid="CR190">190</xref>]? If used in combination with other tools, the answer might be affirmative, the main focus is not to have the maximum clinical effect but to strike a precise and coordinated blow to the parasite reservoir (human and mosquito) to reach a minimum threshold that will compromise its propagation and eventual survival in focal, and eventually global, areas (Figs.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Schematic model of malaria infection and possible outcomes from the human perspective. <italic toggle="yes">Highlighting</italic> potential points of intervention for different strategies for malaria eradication available or under study</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12936_2016_1163_Fig2_HTML.jpg"/></fig><fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>Schematic model of malaria infection and possible outcomes from the mosquito perspective. <italic toggle="yes">Highlighting</italic> potential points of intervention for different strategies for malaria eradication available or under study</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="12936_2016_1163_Fig3_HTML.jpg"/></fig></p><p>Finally, there is the ethical issue behind using medicines without direct therapeutic benefit to patients, even considering the decreased probability of re-infection. Even if there were no direct benefits, one can argue that individuals taking TB medicines or vaccines is a matter of public health. Education and population sensibilization prior implementation, maybe even more than cost and efficacy, is therefore crucial for any strategy to succeed.</p><p>On the other hand, all strategies presented in the &#8216;refractory mosquitoes&#8217; topic are far from implementation; despite some promising results, more knowledge such as the epidemiological effects of releasing modified mosquitoes and biopathogens in the field, is needed [<xref ref-type="bibr" rid="CR164">164</xref>, <xref ref-type="bibr" rid="CR191">191</xref>]. Such unconventional approaches might disfavour public awareness and support, but if enough evidence of the positive impact for malaria elimination is gathered and its scalability is proven, then they could become another weapon in the TBS arsenal.</p></sec></sec><sec id="Sec10"><title>Conclusions</title><p>While it is not expected that TBS will be sufficient to eliminate the disease on their own, their application has the potential to boost other strategies. TBS should be aimed to the lowest endemicity level areas possible (R<sub>0</sub>&#160;&lt;&#160;10) with frequency and timepoints optimized, taking into account not only the immediate impact in the human reservoir of parasites, but also the long term. In addition, efforts to find the best solution for endpoints and regulatory challenges at clinical trials still need to be made and sensibilization campaigns in affected communities to educate about the beneficial issues of TBS should be a priority.</p><p>Any future conventional vaccine for human stages of the disease most likely will be a compromise between efficacy, long-lasting immunity and population coverage. Even if new drugs and insecticides come to market, or resistance against ACT is contained, it is a matter of time until they are rendered ineffective. To achieve malaria elimination, all stages should be targeted, preferably at once, and some of the TBS described here, or others to come, most certainly will have a major role to play.</p></sec></body><back><ack><title>Authors&#8217; contributions</title><p>DG drafted the first version and PH reviewed and approved for submission. Both authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p>The authors want to thank the Swiss Nanoscience Institut for funding and support.</p></sec><sec id="FPar2"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>World malaria report 2014</source><year>2014</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerra</surname><given-names>CA</given-names></name><name name-style="western"><surname>Gikandi</surname><given-names>PW</given-names></name><name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Noor</surname><given-names>AM</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name><etal/></person-group><article-title>The limits and intensity of <italic toggle="yes">Plasmodium falciparum</italic> transmission: implications for malaria control and elimination worldwide</article-title><source>PLoS Med</source><year>2008</year><volume>5</volume><fpage>e38</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0050038</pub-id><pub-id pub-id-type="pmid">18303939</pub-id><pub-id pub-id-type="pmcid">PMC2253602</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerra</surname><given-names>CA</given-names></name><name name-style="western"><surname>Howes</surname><given-names>RE</given-names></name><name name-style="western"><surname>Patil</surname><given-names>AP</given-names></name><name name-style="western"><surname>Gething</surname><given-names>PW</given-names></name><name name-style="western"><surname>Van Boeckel</surname><given-names>TP</given-names></name><name name-style="western"><surname>Temperley</surname><given-names>WH</given-names></name><etal/></person-group><article-title>The international limits and population at risk of <italic toggle="yes">Plasmodium vivax</italic> transmission in 2009</article-title><source>PLoS Negl Trop Dis.</source><year>2010</year><volume>4</volume><fpage>e774</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0000774</pub-id><pub-id pub-id-type="pmid">20689816</pub-id><pub-id pub-id-type="pmcid">PMC2914753</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Malaria Atlas Project. University of Oxford, UK. 2006. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.map.ox.ac.uk/explorer/">http://www.map.ox.ac.uk/explorer/</ext-link> Accessed 21 Aug 2015.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>CJL</given-names></name><name name-style="western"><surname>Rosenfeld</surname><given-names>LC</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SS</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>KG</given-names></name><name name-style="western"><surname>Foreman</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Haring</surname><given-names>D</given-names></name><etal/></person-group><article-title>Global malaria mortality between 1980 and 2010: a systematic analysis</article-title><source>Lancet</source><year>2012</year><volume>379</volume><fpage>413</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)60034-8</pub-id><pub-id pub-id-type="pmid">22305225</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kantele</surname><given-names>A</given-names></name><name name-style="western"><surname>Jokiranta</surname><given-names>TS</given-names></name></person-group><article-title>Review of cases with the emerging fifth human malaria parasite, <italic toggle="yes">Plasmodium knowlesi</italic></article-title><source>Clin Infect Dis</source><year>2011</year><volume>52</volume><fpage>1356</fpage><lpage>1362</lpage><pub-id pub-id-type="doi">10.1093/cid/cir180</pub-id><pub-id pub-id-type="pmid">21596677</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">WHO. MalERA update. World Health Organization, Geneva. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.who.int/malaria/elimination/maleraupdate.pdf">http://www.who.int/malaria/elimination/maleraupdate.pdf</ext-link> of subordinate document. Accessed 13 June 2015.</mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">EMA. First malaria vaccine receives positive scientific opinion from EMA&#8212;London, The European Medicines Agency. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/07/WC500190447.pdf">http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/07/WC500190447.pdf</ext-link> of subordinate document. Accessed 3 Feb 2016.</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>World malaria report 2015</source><year>2015</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dondorp</surname><given-names>AM</given-names></name><name name-style="western"><surname>Nosten</surname><given-names>F</given-names></name><name name-style="western"><surname>Yi</surname><given-names>P</given-names></name><name name-style="western"><surname>Das</surname><given-names>D</given-names></name><name name-style="western"><surname>Phyo</surname><given-names>AP</given-names></name><name name-style="western"><surname>Tarning</surname><given-names>J</given-names></name><etal/></person-group><article-title>Artemisinin resistance in <italic toggle="yes">Plasmodium falciparum</italic> malaria</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><fpage>455</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0808859</pub-id><pub-id pub-id-type="pmid">19641202</pub-id><pub-id pub-id-type="pmcid">PMC3495232</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amaratunga</surname><given-names>C</given-names></name><name name-style="western"><surname>Sreng</surname><given-names>S</given-names></name><name name-style="western"><surname>Suon</surname><given-names>S</given-names></name><name name-style="western"><surname>Phelps</surname><given-names>ES</given-names></name><name name-style="western"><surname>Stepniewska</surname><given-names>K</given-names></name><name name-style="western"><surname>Lim</surname><given-names>P</given-names></name><etal/></person-group><article-title>Artemisinin-resistant <italic toggle="yes">Plasmodium falciparum</italic> in Pursat province, western Cambodia: a parasite clearance rate study</article-title><source>Lancet Infect Dis</source><year>2012</year><volume>12</volume><fpage>851</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(12)70181-0</pub-id><pub-id pub-id-type="pmid">22940027</pub-id><pub-id pub-id-type="pmcid">PMC3786328</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyaw</surname><given-names>MP</given-names></name><name name-style="western"><surname>Nyunt</surname><given-names>MH</given-names></name><name name-style="western"><surname>Chit</surname><given-names>K</given-names></name><name name-style="western"><surname>Aye</surname><given-names>MM</given-names></name><name name-style="western"><surname>Aye</surname><given-names>KH</given-names></name><name name-style="western"><surname>Lindegardh</surname><given-names>N</given-names></name><etal/></person-group><article-title>Reduced susceptibility of <italic toggle="yes">Plasmodium falciparum</italic> to artesunate in southern Myanmar</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e57689</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0057689</pub-id><pub-id pub-id-type="pmid">23520478</pub-id><pub-id pub-id-type="pmcid">PMC3592920</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Brien</surname><given-names>C</given-names></name><name name-style="western"><surname>Henrich</surname><given-names>PP</given-names></name><name name-style="western"><surname>Passi</surname><given-names>N</given-names></name><name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name></person-group><article-title>Recent clinical and molecular insights into emerging artemisinin resistance in <italic toggle="yes">Plasmodium falciparum</italic></article-title><source>Curr Opin Infect Dis</source><year>2011</year><volume>24</volume><fpage>570</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1097/QCO.0b013e32834cd3ed</pub-id><pub-id pub-id-type="pmid">22001944</pub-id><pub-id pub-id-type="pmcid">PMC3268008</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phyo</surname><given-names>AP</given-names></name><name name-style="western"><surname>Nkhoma</surname><given-names>S</given-names></name><name name-style="western"><surname>Stepniewska</surname><given-names>K</given-names></name><name name-style="western"><surname>Ashley</surname><given-names>EA</given-names></name><name name-style="western"><surname>Nair</surname><given-names>S</given-names></name><name name-style="western"><surname>McGready</surname><given-names>R</given-names></name><etal/></person-group><article-title>Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study</article-title><source>Lancet</source><year>2012</year><volume>379</volume><fpage>1960</fpage><lpage>1966</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)60484-X</pub-id><pub-id pub-id-type="pmid">22484134</pub-id><pub-id pub-id-type="pmcid">PMC3525980</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hien</surname><given-names>TT</given-names></name><name name-style="western"><surname>Thuy-Nhien</surname><given-names>NT</given-names></name><name name-style="western"><surname>Phu</surname><given-names>NH</given-names></name><name name-style="western"><surname>Boni</surname><given-names>MF</given-names></name><name name-style="western"><surname>Thanh</surname><given-names>NV</given-names></name><name name-style="western"><surname>Nha-Ca</surname><given-names>NT</given-names></name><etal/></person-group><article-title>In vivo susceptibility <italic toggle="yes">of Plasmodium falciparum</italic> to artesunate in Binh Phuoc province, Vietnam</article-title><source>Malar J</source><year>2012</year><volume>11</volume><fpage>355</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-11-355</pub-id><pub-id pub-id-type="pmid">23101492</pub-id><pub-id pub-id-type="pmcid">PMC3504531</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashley</surname><given-names>EA</given-names></name><name name-style="western"><surname>Dhorda</surname><given-names>M</given-names></name><name name-style="western"><surname>Fairhurst</surname><given-names>RM</given-names></name><name name-style="western"><surname>Amaratunga</surname><given-names>C</given-names></name><name name-style="western"><surname>Lim</surname><given-names>P</given-names></name><name name-style="western"><surname>Suon</surname><given-names>S</given-names></name><etal/></person-group><article-title>Spread of artemisinin resistance in <italic toggle="yes">Plasmodium falciparum</italic> malaria</article-title><source>N Engl J Med</source><year>2014</year><volume>371</volume><fpage>411</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1314981</pub-id><pub-id pub-id-type="pmid">25075834</pub-id><pub-id pub-id-type="pmcid">PMC4143591</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ranson</surname><given-names>H</given-names></name><name name-style="western"><surname>N&#8217;Guessan</surname><given-names>R</given-names></name><name name-style="western"><surname>Lines</surname><given-names>J</given-names></name><name name-style="western"><surname>Moiroux</surname><given-names>N</given-names></name><name name-style="western"><surname>Nkuni</surname><given-names>Z</given-names></name><name name-style="western"><surname>Corbel</surname><given-names>V</given-names></name></person-group><article-title>Pyrethroid resistance in African anopheline mosquitoes: What are the implications for malaria control?</article-title><source>Trends Parasitol</source><year>2011</year><volume>27</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2010.08.004</pub-id><pub-id pub-id-type="pmid">20843745</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Protopopoff</surname><given-names>N</given-names></name><name name-style="western"><surname>Matowo</surname><given-names>J</given-names></name><name name-style="western"><surname>Malima</surname><given-names>R</given-names></name><name name-style="western"><surname>Kavishe</surname><given-names>R</given-names></name><name name-style="western"><surname>Kaaya</surname><given-names>R</given-names></name><name name-style="western"><surname>Wright</surname><given-names>A</given-names></name><etal/></person-group><article-title>High level of resistance in the mosquito <italic toggle="yes">Anopheles gambiae</italic> to pyrethroid insecticides and reduced susceptibility to bendiocarb in north-western Tanzania</article-title><source>Malar J</source><year>2013</year><volume>12</volume><fpage>149</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-12-149</pub-id><pub-id pub-id-type="pmid">23638757</pub-id><pub-id pub-id-type="pmcid">PMC3655935</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>To&#233;</surname><given-names>KH</given-names></name><name name-style="western"><surname>Jones</surname><given-names>CM</given-names></name><name name-style="western"><surname>N&#8217;Fale</surname><given-names>S</given-names></name><name name-style="western"><surname>Ismail</surname><given-names>HM</given-names></name><name name-style="western"><surname>Dabir&#233;</surname><given-names>RK</given-names></name><name name-style="western"><surname>Ranson</surname><given-names>H</given-names></name></person-group><article-title>Increased pyrethroid resistance in malaria vectors and decreased bed net effectiveness, Burkina Faso</article-title><source>Emerg Infect Dis</source><year>2014</year><volume>20</volume><fpage>1691</fpage><lpage>1696</lpage><pub-id pub-id-type="doi">10.3201/eid2010.140619</pub-id><pub-id pub-id-type="pmid">25279965</pub-id><pub-id pub-id-type="pmcid">PMC4193182</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trape</surname><given-names>JF</given-names></name><name name-style="western"><surname>Tall</surname><given-names>A</given-names></name><name name-style="western"><surname>Diagne</surname><given-names>N</given-names></name><name name-style="western"><surname>Ndiath</surname><given-names>O</given-names></name><name name-style="western"><surname>Ly</surname><given-names>AB</given-names></name><name name-style="western"><surname>Faye</surname><given-names>J</given-names></name><etal/></person-group><article-title>Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study</article-title><source>Lancet Infect Dis</source><year>2011</year><volume>11</volume><fpage>925</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(11)70194-3</pub-id><pub-id pub-id-type="pmid">21856232</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Malaria Consortium. Malaria prevention: insecticides. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.malariaconsortium.org/userfiles/file/Malaria%2520resources/Insecticides%25202.pdf">http://www.malariaconsortium.org/userfiles/file/Malaria%20resources/Insecticides%202.pdf</ext-link> of subordinate document. Accessed 6 Sept 2015.</mixed-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisele</surname><given-names>TP</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>D</given-names></name><name name-style="western"><surname>Steketee</surname><given-names>RW</given-names></name></person-group><article-title>Protective efficacy of interventions for preventing malaria mortality in children in <italic toggle="yes">Plasmodium falciparum</italic> endemic areas</article-title><source>Int J Epidemiol</source><year>2010</year><volume>39</volume><fpage>88</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1093/ije/dyq026</pub-id><pub-id pub-id-type="pmcid">PMC2845865</pub-id><pub-id pub-id-type="pmid">20348132</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramirez</surname><given-names>JL</given-names></name><name name-style="western"><surname>Garver</surname><given-names>LS</given-names></name><name name-style="western"><surname>Dimopoulos</surname><given-names>G</given-names></name></person-group><article-title>Challenges and approaches for mosquito targeted malaria control</article-title><source>Curr Mol Med</source><year>2009</year><volume>9</volume><fpage>116</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.2174/156652409787581600</pub-id><pub-id pub-id-type="pmid">19275622</pub-id><pub-id pub-id-type="pmcid">PMC2925229</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nwane</surname><given-names>P</given-names></name><name name-style="western"><surname>Etang</surname><given-names>J</given-names></name><name name-style="western"><surname>Choua&#1111;bou</surname><given-names>M</given-names></name><name name-style="western"><surname>Toto</surname><given-names>JC</given-names></name><name name-style="western"><surname>Koffi</surname><given-names>A</given-names></name><name name-style="western"><surname>Mimpfoundi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Multiple insecticide resistance mechanisms in <italic toggle="yes">Anopheles gambiae s.l.</italic> populations from Cameroon, Central Africa</article-title><source>Parasit Vectors</source><year>2013</year><volume>6</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/1756-3305-6-41</pub-id><pub-id pub-id-type="pmid">23433176</pub-id><pub-id pub-id-type="pmcid">PMC3583743</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>FE</given-names></name></person-group><article-title>Statics and dynamics of malaria infection in Anopheles mosquitoes</article-title><source>Malar J</source><year>2004</year><volume>3</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-3-13</pub-id><pub-id pub-id-type="pmid">15180900</pub-id><pub-id pub-id-type="pmcid">PMC449722</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>FE</given-names></name><name name-style="western"><surname>Snow</surname><given-names>RW</given-names></name><name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name></person-group><article-title>Revisiting the basic reproductive number for malaria and its implications for malaria control</article-title><source>PLoS Biol</source><year>2007</year><volume>5</volume><fpage>e42</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0050042</pub-id><pub-id pub-id-type="pmid">17311470</pub-id><pub-id pub-id-type="pmcid">PMC1802755</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly-Hope</surname><given-names>LA</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>FE</given-names></name></person-group><article-title>The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa</article-title><source>Malar J</source><year>2009</year><volume>8</volume><fpage>19</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-8-19</pub-id><pub-id pub-id-type="pmid">19166589</pub-id><pub-id pub-id-type="pmcid">PMC2656515</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Dushoff</surname><given-names>J</given-names></name><name name-style="western"><surname>Snow</surname><given-names>RW</given-names></name><name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name></person-group><article-title>The entomological inoculation rate and <italic toggle="yes">Plasmodium falciparum</italic> infection in African children</article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>492</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/nature04024</pub-id><pub-id pub-id-type="pmid">16306991</pub-id><pub-id pub-id-type="pmcid">PMC3128496</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#248;gh</surname><given-names>C</given-names></name><name name-style="western"><surname>Lindsay</surname><given-names>SW</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>SE</given-names></name><name name-style="western"><surname>Dean</surname><given-names>A</given-names></name><name name-style="western"><surname>Jawara</surname><given-names>M</given-names></name><name name-style="western"><surname>Pinder</surname><given-names>M</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>CJ</given-names></name></person-group><article-title>High spatial resolution mapping of malaria transmission risk in the Gambia, west Africa, using LANDSAT TM satellite imagery</article-title><source>Am J Trop Med Hyg</source><year>2007</year><volume>76</volume><fpage>875</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">17488908</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>T</given-names></name><name name-style="western"><surname>Schapira</surname><given-names>A</given-names></name></person-group><article-title>Reproduction numbers in malaria and their implications</article-title><source>Trends Parasitol</source><year>2012</year><volume>28</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2011.09.002</pub-id><pub-id pub-id-type="pmid">21996375</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blagborough</surname><given-names>AM</given-names></name><name name-style="western"><surname>Churcher</surname><given-names>TS</given-names></name><name name-style="western"><surname>Upton</surname><given-names>LM</given-names></name><name name-style="western"><surname>Ghani</surname><given-names>AC</given-names></name><name name-style="western"><surname>Gething</surname><given-names>PW</given-names></name><name name-style="western"><surname>Sinden</surname><given-names>RE</given-names></name></person-group><article-title>Transmission-blocking interventions eliminate malaria from laboratory populations</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><fpage>1812</fpage><pub-id pub-id-type="doi">10.1038/ncomms2840</pub-id><pub-id pub-id-type="pmid">23652000</pub-id><pub-id pub-id-type="pmcid">PMC3674233</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macdonald</surname><given-names>G</given-names></name><name name-style="western"><surname>Goeckel</surname><given-names>GW</given-names></name></person-group><article-title>The malaria parasite rate and interruption of transmission</article-title><source>Bull World Health Organ</source><year>1964</year><volume>31</volume><fpage>365</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">14267746</pub-id><pub-id pub-id-type="pmcid">PMC2555125</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>GL</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name></person-group><article-title>Malaria&#8217;s missing number: calculating the human component of R0 by a within-host mechanistic model of <italic toggle="yes">Plasmodium falciparum</italic> infection and transmission</article-title><source>PLoS Comput Biol</source><year>2013</year><volume>9</volume><fpage>e1003025</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003025</pub-id><pub-id pub-id-type="pmid">23637586</pub-id><pub-id pub-id-type="pmcid">PMC3630126</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tusting</surname><given-names>LS</given-names></name><name name-style="western"><surname>Bousema</surname><given-names>T</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></name></person-group><article-title>Measuring changes in <italic toggle="yes">Plasmodium falciparum</italic> transmission: precision, accuracy and costs of metrics</article-title><source>Adv Parasitol</source><year>2014</year><volume>84</volume><fpage>151</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-800099-1.00003-X</pub-id><pub-id pub-id-type="pmid">24480314</pub-id><pub-id pub-id-type="pmcid">PMC4847140</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trape</surname><given-names>JF</given-names></name><name name-style="western"><surname>Lefebvre-Zante</surname><given-names>E</given-names></name><name name-style="western"><surname>Legros</surname><given-names>F</given-names></name><name name-style="western"><surname>Ndiaye</surname><given-names>G</given-names></name><name name-style="western"><surname>Bouganali</surname><given-names>H</given-names></name><name name-style="western"><surname>Druilhe</surname><given-names>P</given-names></name><name name-style="western"><surname>Salem</surname><given-names>G</given-names></name></person-group><article-title>Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal</article-title><source>Am J Trop Med Hyg</source><year>1992</year><volume>47</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">1354414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4269/ajtmh.1992.47.181</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Midega</surname><given-names>JT</given-names></name><name name-style="western"><surname>Mbogo</surname><given-names>CM</given-names></name><name name-style="western"><surname>Mwnambi</surname><given-names>H</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>MD</given-names></name><name name-style="western"><surname>Ojwang</surname><given-names>G</given-names></name><name name-style="western"><surname>Mwangangi</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Estimating dispersal and survival of <italic toggle="yes">Anopheles gambiae</italic> and <italic toggle="yes">Anopheles funestus</italic>&#160;along the Kenyan coast by using mark-release-recapture methods</article-title><source>J Med Entomol</source><year>2007</year><volume>44</volume><fpage>923</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2</pub-id><pub-id pub-id-type="pmid">18047189</pub-id><pub-id pub-id-type="pmcid">PMC2705338</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francia</surname><given-names>ME</given-names></name><name name-style="western"><surname>Striepen</surname><given-names>B</given-names></name></person-group><article-title>Cell division in apicomplexan parasites</article-title><source>Nat Rev Microbiol</source><year>2014</year><volume>12</volume><fpage>125</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3184</pub-id><pub-id pub-id-type="pmid">24384598</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>UM</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>MS</given-names></name><name name-style="western"><surname>Wunderlich</surname><given-names>G</given-names></name></person-group><article-title>Antigenic diversity and immune evasion by malaria parasites</article-title><source>Clin Diagn Lab Immunol</source><year>2004</year><volume>11</volume><fpage>987</fpage><lpage>995</lpage><pub-id pub-id-type="pmid">15539495</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CDLI.11.6.987-995.2004</pub-id><pub-id pub-id-type="pmcid">PMC524792</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirkman</surname><given-names>LA</given-names></name><name name-style="western"><surname>Deitsch</surname><given-names>KW</given-names></name></person-group><article-title>Antigenic variation and the generation of diversity in malaria parasites</article-title><source>Curr Opin Microbiol</source><year>2012</year><volume>15</volume><fpage>456</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2012.03.003</pub-id><pub-id pub-id-type="pmid">22503815</pub-id><pub-id pub-id-type="pmcid">PMC3399988</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prud&#234;ncio</surname><given-names>M</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name><name name-style="western"><surname>Mota</surname><given-names>MM</given-names></name></person-group><article-title>The silent path to thousands of merozoites: the Plasmodium liver stage</article-title><source>Nat Rev Microbiol</source><year>2006</year><volume>4</volume><fpage>849</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1529</pub-id><pub-id pub-id-type="pmid">17041632</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>LH</given-names></name><name name-style="western"><surname>Ackerman</surname><given-names>HC</given-names></name><name name-style="western"><surname>Xin-zhuan</surname><given-names>S</given-names></name><name name-style="western"><surname>Wellems</surname><given-names>TE</given-names></name></person-group><article-title>Malaria biology and disease pathogenesis: insights for new treatments</article-title><source>Nat Med</source><year>2013</year><volume>19</volume><fpage>156</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1038/nm.3073</pub-id><pub-id pub-id-type="pmid">23389616</pub-id><pub-id pub-id-type="pmcid">PMC4783790</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eichner</surname><given-names>M</given-names></name><name name-style="western"><surname>Diebner</surname><given-names>HH</given-names></name><name name-style="western"><surname>Molineaux</surname><given-names>L</given-names></name><name name-style="western"><surname>Collins</surname><given-names>WE</given-names></name><name name-style="western"><surname>Jeffery</surname><given-names>GM</given-names></name><name name-style="western"><surname>Dietz</surname><given-names>K</given-names></name></person-group><article-title>Genesis, sequestration and survival of <italic toggle="yes">Plasmodium falciparum</italic> gametocytes: parameter estimates from fitting a model to malaria therapy data</article-title><source>Trans R Soc Trop Med Hyg</source><year>2001</year><volume>95</volume><fpage>497</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/S0035-9203(01)90016-1</pub-id><pub-id pub-id-type="pmid">11706658</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGuinness</surname><given-names>D</given-names></name><name name-style="western"><surname>Koram</surname><given-names>K</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>S</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>G</given-names></name><name name-style="western"><surname>Nkrumah</surname><given-names>F</given-names></name><name name-style="western"><surname>Riley</surname><given-names>E</given-names></name></person-group><article-title>Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants</article-title><source>Trans R Soc Trop Med Hyg</source><year>1998</year><volume>92</volume><fpage>527</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1016/S0035-9203(98)90902-6</pub-id><pub-id pub-id-type="pmid">9861370</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilairatana</surname><given-names>P</given-names></name><name name-style="western"><surname>Tangpukdee</surname><given-names>N</given-names></name><name name-style="western"><surname>Krudsood</surname><given-names>S</given-names></name></person-group><article-title>Definition of hyperparasitemia in severe falciparum malaria should be updated</article-title><source>Asian Pac J Trop Biomed</source><year>2013</year><volume>3</volume><fpage>586</fpage><pub-id pub-id-type="doi">10.1016/S2221-1691(13)60119-7</pub-id><pub-id pub-id-type="pmid">23835631</pub-id><pub-id pub-id-type="pmcid">PMC3695588</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baton</surname><given-names>LA</given-names></name><name name-style="western"><surname>Ranford-Cartwright</surname><given-names>LC</given-names></name></person-group><article-title>Spreading the seeds of million-murdering death: metamorphoses of malaria in the mosquito</article-title><source>Trends Parasitol</source><year>2005</year><volume>21</volume><fpage>573</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2005.09.012</pub-id><pub-id pub-id-type="pmid">16236552</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Angrisano</surname><given-names>F</given-names></name><name name-style="western"><surname>Tan</surname><given-names>YH</given-names></name><name name-style="western"><surname>Sturm</surname><given-names>A</given-names></name><name name-style="western"><surname>McFadden</surname><given-names>GI</given-names></name><name name-style="western"><surname>Baum</surname><given-names>J</given-names></name></person-group><article-title>Malaria parasite colonisation of the mosquito midgut&#8212;placing the Plasmodium ookinete centre stage</article-title><source>Int J Parasitol</source><year>2012</year><volume>42</volume><fpage>519</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2012.02.004</pub-id><pub-id pub-id-type="pmid">22406332</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vega-Rodr&#237;guez</surname><given-names>J</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Kanzok</surname><given-names>SM</given-names></name><name name-style="western"><surname>Dinglasan</surname><given-names>RR</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Bongio</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Multiple pathways for Plasmodium ookinete invasion of the mosquito midgut</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><fpage>492</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315517111</pub-id><pub-id pub-id-type="pmid">24474798</pub-id><pub-id pub-id-type="pmcid">PMC3910608</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hegedus</surname><given-names>D</given-names></name><name name-style="western"><surname>Erlandson</surname><given-names>M</given-names></name><name name-style="western"><surname>Gillott</surname><given-names>C</given-names></name><name name-style="western"><surname>Toprak</surname><given-names>U</given-names></name></person-group><article-title>New insights into peritrophic matrix synthesis, architecture, and function</article-title><source>Annu Rev Entomol</source><year>2009</year><volume>54</volume><fpage>285</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1146/annurev.ento.54.110807.090559</pub-id><pub-id pub-id-type="pmid">19067633</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>EG</given-names></name><name name-style="western"><surname>Jacobs-Lorena</surname><given-names>M</given-names></name></person-group><article-title>Mosquito midgut barriers to malaria parasite development</article-title><source>Insect Biochem Mol Biol</source><year>2004</year><volume>34</volume><fpage>667</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1016/j.ibmb.2004.03.019</pub-id><pub-id pub-id-type="pmid">15242707</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>YS</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>J</given-names></name><name name-style="western"><surname>Kafatos</surname><given-names>FC</given-names></name><name name-style="western"><surname>Barillas-Mury</surname><given-names>C</given-names></name></person-group><article-title>Molecular interactions between <italic toggle="yes">Anopheles stephensi</italic> midgut cells and <italic toggle="yes">Plasmodium berghei</italic>: the time bomb theory of ookinete invasion of mosquitoes</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>6030</fpage><lpage>6040</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.22.6030</pub-id><pub-id pub-id-type="pmid">11080150</pub-id><pub-id pub-id-type="pmcid">PMC305834</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>YS</given-names></name><name name-style="western"><surname>Barillas-Mury</surname><given-names>C</given-names></name></person-group><article-title>Implications of time bomb model of ookinete invasion of midgut cells</article-title><source>Insect Biochem Mol Biol</source><year>2002</year><volume>32</volume><fpage>1311</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1016/S0965-1748(02)00093-0</pub-id><pub-id pub-id-type="pmid">12225921</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hillyer</surname><given-names>JF</given-names></name><name name-style="western"><surname>Barreau</surname><given-names>C</given-names></name><name name-style="western"><surname>Vernick</surname><given-names>KD</given-names></name></person-group><article-title>Efficiency of salivary gland invasion by malaria sporozoites is controlled by rapid sporozoite destruction in the mosquito hemocoel</article-title><source>Int J Parasitol</source><year>2007</year><volume>37</volume><fpage>673</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2006.12.007</pub-id><pub-id pub-id-type="pmid">17275826</pub-id><pub-id pub-id-type="pmcid">PMC1905829</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medica</surname><given-names>DL</given-names></name><name name-style="western"><surname>Sinnis</surname><given-names>P</given-names></name></person-group><article-title>Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>4363</fpage><lpage>4369</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.7.4363-4369.2005</pub-id><pub-id pub-id-type="pmid">15972531</pub-id><pub-id pub-id-type="pmcid">PMC1168603</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>R</given-names></name><name name-style="western"><surname>Wirtz</surname><given-names>RA</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>I</given-names></name><name name-style="western"><surname>Burge</surname><given-names>R</given-names></name></person-group><article-title>An estimation of the number of malaria sporozoites ejected by a feeding mosquito</article-title><source>Trans R Soc Trop Med Hyg</source><year>1990</year><volume>84</volume><fpage>209</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(90)90258-G</pub-id><pub-id pub-id-type="pmid">2202101</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amino</surname><given-names>R</given-names></name><name name-style="western"><surname>Thiberge</surname><given-names>S</given-names></name><name name-style="western"><surname>Martin</surname><given-names>B</given-names></name><name name-style="western"><surname>Celli</surname><given-names>S</given-names></name><name name-style="western"><surname>Shorte</surname><given-names>S</given-names></name><name name-style="western"><surname>Frischknecht</surname><given-names>F</given-names></name><etal/></person-group><article-title>Quantitative imaging of Plasmodium transmission from mosquito to mammal</article-title><source>Nat Med</source><year>2006</year><volume>12</volume><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1038/nm1350</pub-id><pub-id pub-id-type="pmid">16429144</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cirimotich</surname><given-names>CM</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Garver</surname><given-names>LS</given-names></name><name name-style="western"><surname>Sim</surname><given-names>S</given-names></name><name name-style="western"><surname>Dimopoulos</surname><given-names>G</given-names></name></person-group><article-title>Mosquito immune defenses against Plasmodium infection</article-title><source>Dev Comp Immunol</source><year>2010</year><volume>34</volume><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2009.12.005</pub-id><pub-id pub-id-type="pmid">20026176</pub-id><pub-id pub-id-type="pmcid">PMC3462653</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malaguarnera</surname><given-names>L</given-names></name><name name-style="western"><surname>Musumeci</surname><given-names>S</given-names></name></person-group><article-title>The immune response to <italic toggle="yes">Plasmodium falciparum</italic> malaria</article-title><source>Lancet Infect Dis</source><year>2002</year><volume>2</volume><fpage>472</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(02)00344-4</pub-id><pub-id pub-id-type="pmid">12150846</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>N</given-names></name><name name-style="western"><surname>Karras</surname><given-names>M</given-names></name><name name-style="western"><surname>Raine</surname><given-names>JD</given-names></name><name name-style="western"><surname>Carlton</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kooij</surname><given-names>TW</given-names></name><name name-style="western"><surname>Berriman</surname><given-names>M</given-names></name><etal/></person-group><article-title>A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses</article-title><source>Science</source><year>2005</year><volume>307</volume><fpage>82</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1126/science.1103717</pub-id><pub-id pub-id-type="pmid">15637271</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Florens</surname><given-names>L</given-names></name><name name-style="western"><surname>Washburn</surname><given-names>MP</given-names></name><name name-style="western"><surname>Raine</surname><given-names>JD</given-names></name><name name-style="western"><surname>Anthony</surname><given-names>RM</given-names></name><name name-style="western"><surname>Grainger</surname><given-names>M</given-names></name><name name-style="western"><surname>Haynes</surname><given-names>JD</given-names></name><etal/></person-group><article-title>A proteomic view of the <italic toggle="yes">Plasmodium falciparum</italic> life cycle</article-title><source>Nature</source><year>2002</year><volume>419</volume><fpage>520</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1038/nature01107</pub-id><pub-id pub-id-type="pmid">12368866</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>AM</given-names></name><name name-style="western"><surname>Baggott</surname><given-names>SL</given-names></name><name name-style="western"><surname>Maingon</surname><given-names>R</given-names></name><name name-style="western"><surname>Hurd</surname><given-names>H</given-names></name></person-group><article-title>The costs of mounting an immune response are reflected in the reproductive fitness of the mosquito <italic toggle="yes">Anopheles gambiae</italic></article-title><source>Oikos</source><year>2002</year><volume>97</volume><fpage>371</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0706.2002.970307.x</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hurd</surname><given-names>H</given-names></name></person-group><article-title>Manipulation of medically important insect vectors by their parasites</article-title><source>Annu Rev Entomol</source><year>2003</year><volume>48</volume><fpage>141</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1146/annurev.ento.48.091801.112722</pub-id><pub-id pub-id-type="pmid">12414739</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sangare</surname><given-names>I</given-names></name><name name-style="western"><surname>Michalakis</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yameogo</surname><given-names>B</given-names></name><name name-style="western"><surname>Dabire</surname><given-names>R</given-names></name><name name-style="western"><surname>Morlais</surname><given-names>I</given-names></name><name name-style="western"><surname>Cohuet</surname><given-names>A</given-names></name></person-group><article-title>Studying fitness cost of <italic toggle="yes">Plasmodium falciparum</italic> infection in malaria vectors: validation of an appropriate negative control</article-title><source>Malar J</source><year>2013</year><volume>12</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-12-2</pub-id><pub-id pub-id-type="pmid">23282172</pub-id><pub-id pub-id-type="pmcid">PMC3543248</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>R</given-names></name><name name-style="western"><surname>Miller</surname><given-names>LH</given-names></name></person-group><article-title>Evidence for environmental modulation of gametocytogenesis in <italic toggle="yes">Plasmodium falciparum</italic> in continuous culture</article-title><source>Bull World Health Organ</source><year>1979</year><volume>57</volume><fpage>37</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">397008</pub-id><pub-id pub-id-type="pmcid">PMC2395706</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruce</surname><given-names>MC</given-names></name><name name-style="western"><surname>Alano</surname><given-names>P</given-names></name><name name-style="western"><surname>Duthie</surname><given-names>S</given-names></name><name name-style="western"><surname>Carter</surname><given-names>R</given-names></name></person-group><article-title>Commitment of the malaria parasite <italic toggle="yes">Plasmodium falciparum</italic> to sexual and asexual development</article-title><source>Parasitology</source><year>1990</year><volume>100</volume><fpage>191</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1017/S0031182000061199</pub-id><pub-id pub-id-type="pmid">2189114</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>TG</given-names></name><name name-style="western"><surname>Louren&#231;o</surname><given-names>P</given-names></name><name name-style="western"><surname>Carter</surname><given-names>R</given-names></name><name name-style="western"><surname>Walliker</surname><given-names>D</given-names></name><name name-style="western"><surname>Ranford-Cartwright</surname><given-names>LC</given-names></name></person-group><article-title>Commitment to sexual differentiation in the human malaria parasite, <italic toggle="yes">Plasmodium falciparum</italic></article-title><source>Parasitology</source><year>2000</year><volume>121</volume><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1017/S0031182099006265</pub-id><pub-id pub-id-type="pmid">11085232</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitri</surname><given-names>C</given-names></name><name name-style="western"><surname>Thiery</surname><given-names>I</given-names></name><name name-style="western"><surname>Bourgouin</surname><given-names>C</given-names></name><name name-style="western"><surname>Paul</surname><given-names>RE</given-names></name></person-group><article-title>Density-dependent impact of the human malaria parasite <italic toggle="yes">Plasmodium falciparum</italic> gametocyte sex ratio on mosquito infection rates</article-title><source>Proc Biol Sci</source><year>2009</year><volume>276</volume><fpage>3721</fpage><lpage>3726</lpage><pub-id pub-id-type="doi">10.1098/rspb.2009.0962</pub-id><pub-id pub-id-type="pmid">19656795</pub-id><pub-id pub-id-type="pmcid">PMC2817308</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>DA</given-names></name></person-group><article-title>Malaria gametocytogenesis</article-title><source>Mol Biochem Parasitol</source><year>2010</year><volume>172</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2010.03.019</pub-id><pub-id pub-id-type="pmid">20381542</pub-id><pub-id pub-id-type="pmcid">PMC2880792</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>A</given-names></name><name name-style="western"><surname>Killeen</surname><given-names>G</given-names></name><name name-style="western"><surname>Smith</surname><given-names>T</given-names></name></person-group><article-title>Relationships between host infectivity to mosquitoes and asexual parasite density in <italic toggle="yes">Plasmodium falciparum</italic></article-title><source>Am J Trop Med Hyg</source><year>2006</year><volume>75</volume><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">16931813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4269/ajtmh.2006.75.32</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuehn</surname><given-names>A</given-names></name><name name-style="western"><surname>Pradel</surname><given-names>G</given-names></name></person-group><article-title>The coming-out of malaria gametocytes</article-title><source>J Biomed Biotechnol</source><year>2010</year><volume>2010</volume><fpage>976827</fpage><pub-id pub-id-type="doi">10.1155/2010/976827</pub-id><pub-id pub-id-type="pmid">20111746</pub-id><pub-id pub-id-type="pmcid">PMC2810480</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bousema</surname><given-names>T</given-names></name><name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></name></person-group><article-title>Epidemiology and infectivity of <italic toggle="yes">Plasmodium falciparum</italic> and <italic toggle="yes">Plasmodium vivax</italic> gametocytes in relation to malaria control and elimination</article-title><source>Clin Microbiol Rev</source><year>2011</year><volume>24</volume><fpage>377</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1128/CMR.00051-10</pub-id><pub-id pub-id-type="pmid">21482730</pub-id><pub-id pub-id-type="pmcid">PMC3122489</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bousema</surname><given-names>T</given-names></name><name name-style="western"><surname>Okell</surname><given-names>L</given-names></name><name name-style="western"><surname>Shekalaghe</surname><given-names>S</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>JT</given-names></name><name name-style="western"><surname>Omar</surname><given-names>S</given-names></name><name name-style="western"><surname>Sawa</surname><given-names>P</given-names></name><etal/></person-group><article-title>Revisiting the circulation time of <italic toggle="yes">Plasmodium falciparum</italic> gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs</article-title><source>Malar J</source><year>2010</year><volume>9</volume><fpage>136</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-9-136</pub-id><pub-id pub-id-type="pmid">20497536</pub-id><pub-id pub-id-type="pmcid">PMC2881938</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smalley</surname><given-names>ME</given-names></name><name name-style="western"><surname>Sinden</surname><given-names>RE</given-names></name></person-group><article-title><italic toggle="yes">Plasmodium falciparum</italic> gametocytes: their longevity and infectivity</article-title><source>Parasitology</source><year>1977</year><volume>74</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1017/S0031182000047478</pub-id><pub-id pub-id-type="pmid">320542</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>P</given-names></name><name name-style="western"><surname>Bousema</surname><given-names>JT</given-names></name><name name-style="western"><surname>Gouagna</surname><given-names>LC</given-names></name><name name-style="western"><surname>Otieno</surname><given-names>S</given-names></name><name name-style="western"><surname>van de Vegte-Bolmer</surname><given-names>M</given-names></name><name name-style="western"><surname>Omar</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Submicroscopic <italic toggle="yes">Plasmodium falciparum</italic> gametocyte densities frequently result in mosquito infection</article-title><source>Am J Trop Med Hyg</source><year>2007</year><volume>76</volume><fpage>470</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">17360869</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eckhoff</surname><given-names>P</given-names></name></person-group><article-title><italic toggle="yes">P. falciparum</italic> infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e44950</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0044950</pub-id><pub-id pub-id-type="pmid">23028698</pub-id><pub-id pub-id-type="pmcid">PMC3446976</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da</surname><given-names>DF</given-names></name><name name-style="western"><surname>Churcher</surname><given-names>TS</given-names></name><name name-style="western"><surname>Yerbanga</surname><given-names>RS</given-names></name><name name-style="western"><surname>Yam&#233;ogo</surname><given-names>B</given-names></name><name name-style="western"><surname>Sangar&#233;</surname><given-names>I</given-names></name><name name-style="western"><surname>Ouedraogo</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Experimental study of the relationship between Plasmodium gametocyte density and infection success in mosquitoes; implications for the evaluation of malaria transmission-reducing interventions</article-title><source>Exp Parasitol</source><year>2015</year><volume>149</volume><fpage>74</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2014.12.010</pub-id><pub-id pub-id-type="pmid">25541384</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bousema</surname><given-names>T</given-names></name><name name-style="western"><surname>Okell</surname><given-names>L</given-names></name><name name-style="western"><surname>Felger</surname><given-names>I</given-names></name><name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></name></person-group><article-title>Asymptomatic malaria infections: detectability, transmissibility and public health relevance</article-title><source>Nat Rev Microbiol</source><year>2014</year><volume>12</volume><fpage>833</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3364</pub-id><pub-id pub-id-type="pmid">25329408</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wampfler</surname><given-names>R</given-names></name><name name-style="western"><surname>Mwingira</surname><given-names>F</given-names></name><name name-style="western"><surname>Javati</surname><given-names>S</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>L</given-names></name><name name-style="western"><surname>Betuela</surname><given-names>I</given-names></name><name name-style="western"><surname>Siba</surname><given-names>P</given-names></name><etal/></person-group><article-title>Strategies for detection of Plasmodium species gametocytes</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e76316</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0076316</pub-id><pub-id pub-id-type="pmid">24312682</pub-id><pub-id pub-id-type="pmcid">PMC3848260</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>P</given-names></name><name name-style="western"><surname>Schoone</surname><given-names>G</given-names></name><name name-style="western"><surname>Schallig</surname><given-names>H</given-names></name><name name-style="western"><surname>Verhage</surname><given-names>D</given-names></name><name name-style="western"><surname>Telgt</surname><given-names>D</given-names></name><name name-style="western"><surname>Eling</surname><given-names>W</given-names></name><etal/></person-group><article-title>Quantification of <italic toggle="yes">Plasmodium falciparum</italic> gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification</article-title><source>Mol Biochem Parasitol</source><year>2004</year><volume>137</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2004.03.018</pub-id><pub-id pub-id-type="pmid">15279949</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karl</surname><given-names>Stephan</given-names></name></person-group><article-title>Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria</article-title><source>Malar J</source><year>2014</year><volume>13</volume><fpage>319</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-13-319</pub-id><pub-id pub-id-type="pmid">25123055</pub-id><pub-id pub-id-type="pmcid">PMC4139605</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">WPRO. Determining cost effectiveness of malaria rapid diagnostic tests in rural areas with high prevalence&#8212;Manila. World Health Organization Western Pacific Region. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.wpro.who.int/malaria/NR/rdonlyres/0A45DF24-4245-4BF3-96E7-5F1150AF333B/0/DeterminingCostEffectivenessofRDTsinruralareaswithhighprevalence.pdf">http://www.wpro.who.int/malaria/NR/rdonlyres/0A45DF24-4245-4BF3-96E7-5F1150AF333B/0/DeterminingCostEffectivenessofRDTsinruralareaswithhighprevalence.pdf</ext-link> of subordinate document. Accessed 3 Feb 2016.</mixed-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansen</surname><given-names>KS</given-names></name><name name-style="western"><surname>Grieve</surname><given-names>E</given-names></name><name name-style="western"><surname>Mikhail</surname><given-names>A</given-names></name><name name-style="western"><surname>Mayan</surname><given-names>I</given-names></name><name name-style="western"><surname>Mohammed</surname><given-names>N</given-names></name><name name-style="western"><surname>Anwar</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan</article-title><source>Malar J</source><year>2015</year><volume>14</volume><fpage>217</fpage><pub-id pub-id-type="doi">10.1186/s12936-015-0696-1</pub-id><pub-id pub-id-type="pmid">26016871</pub-id><pub-id pub-id-type="pmcid">PMC4450447</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ansah</surname><given-names>EK</given-names></name><name name-style="western"><surname>Epokor</surname><given-names>M</given-names></name><name name-style="western"><surname>Whitty</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>S</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>KS</given-names></name></person-group><article-title>Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana</article-title><source>Am J Trop Med Hyg</source><year>2013</year><volume>89</volume><fpage>724</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.13-0033</pub-id><pub-id pub-id-type="pmid">23980131</pub-id><pub-id pub-id-type="pmcid">PMC3795104</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>J</given-names></name><name name-style="western"><surname>Aydin-Schmidt</surname><given-names>B</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Bell</surname><given-names>D</given-names></name><name name-style="western"><surname>Edlund</surname><given-names>E</given-names></name><name name-style="western"><surname>Nassor</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Loop-mediated isothermal amplification (LAMP) for point-of-care detection of asymptomatic low-density malaria parasite carriers in Zanzibar</article-title><source>Malar J</source><year>2015</year><volume>14</volume><fpage>43</fpage><pub-id pub-id-type="doi">10.1186/s12936-015-0573-y</pub-id><pub-id pub-id-type="pmid">25627037</pub-id><pub-id pub-id-type="pmcid">PMC4318361</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Githeko</surname><given-names>AK</given-names></name><name name-style="western"><surname>Brandling-Bennett</surname><given-names>AD</given-names></name><name name-style="western"><surname>Beier</surname><given-names>M</given-names></name><name name-style="western"><surname>Atieli</surname><given-names>F</given-names></name><name name-style="western"><surname>Owaga</surname><given-names>M</given-names></name><name name-style="western"><surname>Collins</surname><given-names>FH</given-names></name></person-group><article-title>The reservoir of <italic toggle="yes">Plasmodium falciparum</italic> malaria in a holoendemic area of western Kenya</article-title><source>Trans R Soc Trop Med Hyg</source><year>1992</year><volume>86</volume><fpage>355</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(92)90216-Y</pub-id><pub-id pub-id-type="pmid">1359683</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonnet</surname><given-names>S</given-names></name><name name-style="western"><surname>Gouagna</surname><given-names>LC</given-names></name><name name-style="western"><surname>Paul</surname><given-names>RE</given-names></name><name name-style="western"><surname>Safeukui</surname><given-names>I</given-names></name><name name-style="western"><surname>Meunier</surname><given-names>JY</given-names></name><name name-style="western"><surname>Boudin</surname><given-names>C</given-names></name></person-group><article-title>Estimation of malaria transmission from humans to mosquitoes in two neighbouring villages in south Cameroon: evaluation and comparison of several indices</article-title><source>Trans R Soc Trop Med Hyg</source><year>2003</year><volume>97</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/S0035-9203(03)90022-8</pub-id><pub-id pub-id-type="pmid">12886806</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Churcher</surname><given-names>TS</given-names></name><name name-style="western"><surname>Bousema</surname><given-names>T</given-names></name><name name-style="western"><surname>Walker</surname><given-names>M</given-names></name><name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>P</given-names></name><name name-style="western"><surname>Ou&#233;draogo</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Predicting mosquito infection from <italic toggle="yes">Plasmodium falciparum</italic> gametocyte density and estimating the reservoir of infection</article-title><source>Elife</source><year>2013</year><volume>2</volume><fpage>e00626</fpage><pub-id pub-id-type="doi">10.7554/eLife.00626</pub-id><pub-id pub-id-type="pmid">23705071</pub-id><pub-id pub-id-type="pmcid">PMC3660740</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drakeley</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Bousema</surname><given-names>JT</given-names></name><name name-style="western"><surname>Akim</surname><given-names>NI</given-names></name><name name-style="western"><surname>Teelen</surname><given-names>K</given-names></name><name name-style="western"><surname>Roeffen</surname><given-names>W</given-names></name><name name-style="western"><surname>Lensen</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Transmission-reducing immunity is inversely related to age in <italic toggle="yes">Plasmodium falciparum</italic> gametocyte carriers</article-title><source>Parasite Immunol</source><year>2006</year><volume>28</volume><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3024.2005.00818.x</pub-id><pub-id pub-id-type="pmid">16629703</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haji</surname><given-names>H</given-names></name><name name-style="western"><surname>Smith</surname><given-names>T</given-names></name><name name-style="western"><surname>Charlwood</surname><given-names>JD</given-names></name><name name-style="western"><surname>Meuwissen</surname><given-names>JH</given-names></name></person-group><article-title>Absence of relationships between selected human factors and natural infectivity of <italic toggle="yes">Plasmodium falciparum</italic> to mosquitoes in an area of high transmission</article-title><source>Parasitology</source><year>1996</year><volume>113</volume><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1017/S0031182000081488</pub-id><pub-id pub-id-type="pmid">8893528</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bousema</surname><given-names>T</given-names></name><name name-style="western"><surname>Churcher</surname><given-names>TS</given-names></name><name name-style="western"><surname>Morlais</surname><given-names>I</given-names></name><name name-style="western"><surname>Dinglasan</surname><given-names>RR</given-names></name></person-group><article-title>Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions?</article-title><source>Trends Parasitol</source><year>2013</year><volume>29</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2012.11.004</pub-id><pub-id pub-id-type="pmid">23273727</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pukrittayakamee</surname><given-names>S</given-names></name><name name-style="western"><surname>Chotivanich</surname><given-names>K</given-names></name><name name-style="western"><surname>Chantra</surname><given-names>A</given-names></name><name name-style="western"><surname>Clemens</surname><given-names>R</given-names></name><name name-style="western"><surname>Looareesuwan</surname><given-names>S</given-names></name><name name-style="western"><surname>White</surname><given-names>NJ</given-names></name></person-group><article-title>Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria</article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><fpage>1329</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1128/AAC.48.4.1329-1334.2004</pub-id><pub-id pub-id-type="pmid">15047537</pub-id><pub-id pub-id-type="pmcid">PMC375327</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>J</given-names></name><name name-style="western"><surname>Socheat</surname><given-names>D</given-names></name><name name-style="western"><surname>Tan</surname><given-names>B</given-names></name><name name-style="western"><surname>Dara</surname><given-names>P</given-names></name><name name-style="western"><surname>Deng</surname><given-names>C</given-names></name><name name-style="western"><surname>Sokunthea</surname><given-names>S</given-names></name><etal/></person-group><article-title>Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine</article-title><source>Malaria J</source><year>2010</year><volume>9</volume><fpage>57</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-9-57</pub-id><pub-id pub-id-type="pmcid">PMC2837675</pub-id><pub-id pub-id-type="pmid">20175930</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graves</surname><given-names>PM</given-names></name><name name-style="western"><surname>Gelband</surname><given-names>H</given-names></name><name name-style="western"><surname>Garner</surname><given-names>P</given-names></name></person-group><article-title>Primaquine or other 8-aminoquinoline for reducing <italic toggle="yes">Plasmodium falciparum</italic> transmission</article-title><source>Cochrane Database Syst Rev</source><year>2015</year><volume>6</volume><fpage>CD008152</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD008152.pub4</pub-id><pub-id pub-id-type="pmcid">PMC4455224</pub-id><pub-id pub-id-type="pmid">25693791</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maude</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Socheat</surname><given-names>D</given-names></name><name name-style="western"><surname>Nguon</surname><given-names>C</given-names></name><name name-style="western"><surname>Saroth</surname><given-names>P</given-names></name><name name-style="western"><surname>Dara</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><etal/></person-group><article-title>Optimising strategies for <italic toggle="yes">Plasmodium falciparum</italic> malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e37166</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0037166</pub-id><pub-id pub-id-type="pmid">22662135</pub-id><pub-id pub-id-type="pmcid">PMC3360685</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baird</surname><given-names>JK</given-names></name><name name-style="western"><surname>Surjadjaja</surname><given-names>C</given-names></name></person-group><article-title>Consideration of ethics in primaquine therapy against malaria transmission</article-title><source>Trends Parasitol</source><year>2011</year><volume>27</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2010.08.005</pub-id><pub-id pub-id-type="pmid">20846906</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eziefula</surname><given-names>AC</given-names></name><name name-style="western"><surname>Bousema</surname><given-names>T</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>S</given-names></name><name name-style="western"><surname>Kamya</surname><given-names>M</given-names></name><name name-style="western"><surname>Owaraganise</surname><given-names>A</given-names></name><name name-style="western"><surname>Gabagaya</surname><given-names>G</given-names></name><etal/></person-group><article-title>Single dose primaquine for clearance of <italic toggle="yes">Plasmodium falciparum</italic> gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial</article-title><source>Lancet Infect Dis</source><year>2014</year><volume>14</volume><fpage>130</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(13)70268-8</pub-id><pub-id pub-id-type="pmid">24239324</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>Guidelines for the treatment of malaria</source><year>2015</year><edition>3</edition><publisher-loc>Geneva</publisher-loc><publisher-name>WHO Library Cataloguing-in-Publication Data</publisher-name></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pukrittayakamee</surname><given-names>S</given-names></name><name name-style="western"><surname>Imwong</surname><given-names>M</given-names></name><name name-style="western"><surname>Singhasivanon</surname><given-names>P</given-names></name><name name-style="western"><surname>Stepniewska</surname><given-names>K</given-names></name><name name-style="western"><surname>Day</surname><given-names>NJ</given-names></name><name name-style="western"><surname>White</surname><given-names>NJ</given-names></name></person-group><article-title>Effects of different antimalarial drugs on gametocyte carriage in <italic toggle="yes">P. vivax</italic> malaria</article-title><source>Am J Trop Med Hyg</source><year>2008</year><volume>79</volume><fpage>378</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">18784229</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Silachamroon</surname><given-names>U</given-names></name><name name-style="western"><surname>Singhasivanon</surname><given-names>P</given-names></name><name name-style="western"><surname>Wilairatana</surname><given-names>P</given-names></name><name name-style="western"><surname>Phumratanaprapin</surname><given-names>W</given-names></name><name name-style="western"><surname>Fontanet</surname><given-names>A</given-names></name><etal/></person-group><article-title>Comparison of artesunate and chloroquine activities against <italic toggle="yes">Plasmodium vivax</italic> gametocytes</article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><fpage>2751</fpage><lpage>2752</lpage><pub-id pub-id-type="doi">10.1128/AAC.48.7.2751-2752.2004</pub-id><pub-id pub-id-type="pmid">15215143</pub-id><pub-id pub-id-type="pmcid">PMC434160</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeeman</surname><given-names>AM</given-names></name><name name-style="western"><surname>der Wel</surname><given-names>AV</given-names></name><name name-style="western"><surname>Kocken</surname><given-names>CH</given-names></name></person-group><article-title>Ex vivo culture of <italic toggle="yes">Plasmodium vivax</italic> and <italic toggle="yes">Plasmodium cynomolgi</italic> and in vitro culture of <italic toggle="yes">Plasmodium knowlesi</italic> blood stages</article-title><source>Methods Mol Biol</source><year>2013</year><volume>923</volume><fpage>35</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-026-7_4</pub-id><pub-id pub-id-type="pmid">22990770</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McClean</surname><given-names>CM</given-names></name><name name-style="western"><surname>Alvarado</surname><given-names>HG</given-names></name><name name-style="western"><surname>Neyra</surname><given-names>V</given-names></name><name name-style="western"><surname>Llanos-Cuentas</surname><given-names>A</given-names></name><name name-style="western"><surname>Vinetz</surname><given-names>JM</given-names></name></person-group><article-title>Optimized in vitro production of <italic toggle="yes">Plasmodium vivax</italic> ookinetes</article-title><source>Am J Trop Med Hyg</source><year>2010</year><volume>83</volume><fpage>1183</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2010.10-0195</pub-id><pub-id pub-id-type="pmid">21118919</pub-id><pub-id pub-id-type="pmcid">PMC2990029</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fivelman</surname><given-names>QL</given-names></name><name name-style="western"><surname>McRobert</surname><given-names>L</given-names></name><name name-style="western"><surname>Sharp</surname><given-names>S</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>M</given-names></name><name name-style="western"><surname>Swales</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Improved synchronous production of <italic toggle="yes">Plasmodium falciparum</italic> gametocytes in vitro</article-title><source>Mol Biochem Parasitol</source><year>2007</year><volume>154</volume><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2007.04.008</pub-id><pub-id pub-id-type="pmid">17521751</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roncal&#233;s</surname><given-names>M</given-names></name><name name-style="western"><surname>Vidal-Mas</surname><given-names>J</given-names></name><name name-style="western"><surname>Leroy</surname><given-names>D</given-names></name><name name-style="western"><surname>Herreros</surname><given-names>E</given-names></name></person-group><article-title>Comparison and optimization of different methods for the in vitro production of <italic toggle="yes">Plasmodium falciparum</italic> gametocytes</article-title><source>J Parasit Res</source><year>2012</year><volume>2012</volume><fpage>927148</fpage><pub-id pub-id-type="doi">10.1155/2012/927148</pub-id><pub-id pub-id-type="pmcid">PMC3317192</pub-id><pub-id pub-id-type="pmid">22523643</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Dinglasan</surname><given-names>RR</given-names></name><name name-style="western"><surname>Ikadai</surname><given-names>H</given-names></name><name name-style="western"><surname>Jacobs-Lorena</surname><given-names>M</given-names></name></person-group><article-title>An improved method for the in vitro differentiation of <italic toggle="yes">Plasmodium falciparum</italic> gametocytes into ookinetes</article-title><source>Malar J</source><year>2010</year><volume>9</volume><fpage>194</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-9-194</pub-id><pub-id pub-id-type="pmid">20615232</pub-id><pub-id pub-id-type="pmcid">PMC2909250</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bounkeua</surname><given-names>V</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Vinetz</surname><given-names>JM</given-names></name></person-group><article-title>In vitro generation of <italic toggle="yes">Plasmodium falciparum</italic> ookinetes</article-title><source>Am J Trop Med Hyg</source><year>2010</year><volume>83</volume><fpage>1187</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2010.10-0433</pub-id><pub-id pub-id-type="pmid">21118920</pub-id><pub-id pub-id-type="pmcid">PMC2990030</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delves</surname><given-names>M</given-names></name><name name-style="western"><surname>Plouffe</surname><given-names>D</given-names></name><name name-style="western"><surname>Scheurer</surname><given-names>C</given-names></name><name name-style="western"><surname>Meister</surname><given-names>S</given-names></name><name name-style="western"><surname>Wittlin</surname><given-names>S</given-names></name><name name-style="western"><surname>Winzeler</surname><given-names>EA</given-names></name><etal/></person-group><article-title>The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites</article-title><source>PLoS Med</source><year>2012</year><volume>9</volume><fpage>e1001169</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001169</pub-id><pub-id pub-id-type="pmid">22363211</pub-id><pub-id pub-id-type="pmcid">PMC3283556</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peatey</surname><given-names>CL</given-names></name><name name-style="western"><surname>Leroy</surname><given-names>D</given-names></name><name name-style="western"><surname>Gardiner</surname><given-names>DL</given-names></name><name name-style="western"><surname>Trenholme</surname><given-names>KR</given-names></name></person-group><article-title>Anti-malarial drugs: how effective are they against <italic toggle="yes">Plasmodium falciparum</italic> gametocytes</article-title><source>Malar J</source><year>2012</year><volume>11</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-11-34</pub-id><pub-id pub-id-type="pmid">22305482</pub-id><pub-id pub-id-type="pmcid">PMC3293736</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leli&#232;vre</surname><given-names>J</given-names></name><name name-style="western"><surname>Almela</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Lozano</surname><given-names>S</given-names></name><name name-style="western"><surname>Miguel</surname><given-names>C</given-names></name><name name-style="western"><surname>Franco</surname><given-names>V</given-names></name><name name-style="western"><surname>Leroy</surname><given-names>D</given-names></name><etal/></person-group><article-title>Activity of clinically relevant antimalarial drugs on <italic toggle="yes">Plasmodium falciparum</italic> mature gametocytes in na ATP bioluminescence &#8220;transmission blocking&#8221; assay</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e35019</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0035019</pub-id><pub-id pub-id-type="pmid">22514702</pub-id><pub-id pub-id-type="pmcid">PMC3325938</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>TQ</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>KC</given-names></name></person-group><article-title>A malaria gametocytocidal assay using oxidoreduction indicator, Alamar Blue</article-title><source>Mol Biochem Parasitol</source><year>2011</year><volume>177</volume><fpage>160</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2011.02.005</pub-id><pub-id pub-id-type="pmid">21316401</pub-id><pub-id pub-id-type="pmcid">PMC3075389</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duffy</surname><given-names>S</given-names></name><name name-style="western"><surname>Avery</surname><given-names>VM</given-names></name></person-group><article-title>Identification of inhibitors of <italic toggle="yes">Plasmodium falciparum</italic> gametocyte development</article-title><source>Malar J</source><year>2013</year><volume>12</volume><fpage>408</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-12-408</pub-id><pub-id pub-id-type="pmid">24206914</pub-id><pub-id pub-id-type="pmcid">PMC3842684</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buchholz</surname><given-names>K</given-names></name><name name-style="western"><surname>Burke</surname><given-names>TA</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>KC</given-names></name><name name-style="western"><surname>Wiegand</surname><given-names>RC</given-names></name><name name-style="western"><surname>Wirth</surname><given-names>DF</given-names></name><name name-style="western"><surname>Marti</surname><given-names>M</given-names></name></person-group><article-title>A high-throughput screen targeting malaria transmission stages opens new avenues for drug development</article-title><source>J Infect Dis</source><year>2011</year><volume>203</volume><fpage>1445</fpage><lpage>1453</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir037</pub-id><pub-id pub-id-type="pmid">21502082</pub-id><pub-id pub-id-type="pmcid">PMC3080890</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peatey</surname><given-names>CL</given-names></name><name name-style="western"><surname>Spicer</surname><given-names>TP</given-names></name><name name-style="western"><surname>Hodder</surname><given-names>PS</given-names></name><name name-style="western"><surname>Trenholme</surname><given-names>KR</given-names></name><name name-style="western"><surname>Gardiner</surname><given-names>DL</given-names></name></person-group><article-title>A high-throughput assay for the identification of drugs against late-stage <italic toggle="yes">Plasmodium falciparum</italic> gametocytes</article-title><source>Mol Biochem Parasitol</source><year>2011</year><volume>180</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2011.09.002</pub-id><pub-id pub-id-type="pmid">21939693</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miguel-Blanco</surname><given-names>C</given-names></name><name name-style="western"><surname>Leli&#232;vre</surname><given-names>J</given-names></name><name name-style="western"><surname>Delves</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bardera</surname><given-names>AI</given-names></name><name name-style="western"><surname>Presa</surname><given-names>JL</given-names></name><name name-style="western"><surname>L&#243;pez-Barrag&#225;n</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against <italic toggle="yes">Plasmodium falciparum</italic> female gamete formation</article-title><source>Antimicrob Agents Chemother</source><year>2015</year><volume>59</volume><fpage>3298</fpage><lpage>3305</lpage><pub-id pub-id-type="doi">10.1128/AAC.04684-14</pub-id><pub-id pub-id-type="pmid">25801574</pub-id><pub-id pub-id-type="pmcid">PMC4432159</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gamo</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Sanz</surname><given-names>LM</given-names></name><name name-style="western"><surname>Vidal</surname><given-names>J</given-names></name><name name-style="western"><surname>de Cozar</surname><given-names>C</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>E</given-names></name><name name-style="western"><surname>Lavandera</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Thousands of chemical starting points for antimalarial lead identification</article-title><source>Nature</source><year>2010</year><volume>465</volume><fpage>305</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1038/nature09107</pub-id><pub-id pub-id-type="pmid">20485427</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rieckmann</surname><given-names>KH</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>JV</given-names></name><name name-style="western"><surname>Frischer</surname><given-names>H</given-names></name><name name-style="western"><surname>Stockert</surname><given-names>TA</given-names></name><name name-style="western"><surname>Carson</surname><given-names>PE</given-names></name><name name-style="western"><surname>Powell</surname><given-names>RD</given-names></name></person-group><article-title>Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of <italic toggle="yes">Plasmodium falciparum</italic></article-title><source>Bull World Health Organ</source><year>1968</year><volume>38</volume><fpage>625</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">4876731</pub-id><pub-id pub-id-type="pmcid">PMC2554527</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilairatana</surname><given-names>P</given-names></name><name name-style="western"><surname>Krudsood</surname><given-names>S</given-names></name><name name-style="western"><surname>Tangpukdee</surname><given-names>N</given-names></name></person-group><article-title>Appropriate time for primaquine treatment to reduce <italic toggle="yes">Plasmodium falciparum</italic> transmission in hypoendemic areas</article-title><source>Korean J Parasitol</source><year>2010</year><volume>48</volume><fpage>179</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.3347/kjp.2010.48.2.179</pub-id><pub-id pub-id-type="pmid">20585538</pub-id><pub-id pub-id-type="pmcid">PMC2892577</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawpoolsri</surname><given-names>S</given-names></name><name name-style="western"><surname>Klein</surname><given-names>EY</given-names></name><name name-style="western"><surname>Singhasivanon</surname><given-names>P</given-names></name><name name-style="western"><surname>Yimsamran</surname><given-names>S</given-names></name><name name-style="western"><surname>Thanyavanich</surname><given-names>N</given-names></name><name name-style="western"><surname>Maneeboonyang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Optimally timing primaquine treatment to reduce <italic toggle="yes">Plasmodium falciparum</italic> transmission in low endemicity Thai-Myanmar border populations</article-title><source>Malar J</source><year>2009</year><volume>8</volume><fpage>159</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-8-159</pub-id><pub-id pub-id-type="pmid">19604346</pub-id><pub-id pub-id-type="pmcid">PMC2718908</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hastings</surname><given-names>IM</given-names></name></person-group><article-title>Gametocytocidal activity in antimalarial drugs speeds the spread of drug resistance</article-title><source>Trop Med Int Health</source><year>2006</year><volume>11</volume><fpage>1206</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2006.01668.x</pub-id><pub-id pub-id-type="pmid">16903884</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talisuna</surname><given-names>AO</given-names></name><name name-style="western"><surname>Okello</surname><given-names>PE</given-names></name><name name-style="western"><surname>Erhart</surname><given-names>A</given-names></name><name name-style="western"><surname>Coosemans</surname><given-names>M</given-names></name><name name-style="western"><surname>D&#8217;Alessandro</surname><given-names>U</given-names></name></person-group><article-title>Intensity of malaria transmission and the spread of <italic toggle="yes">Plasmodium falciparum</italic>&#8211;resistant malaria: a review of epidemiologic field evidence</article-title><source>Am J Trop Med Hyg</source><year>2007</year><volume>77</volume><fpage>170</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">18165490</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talisuna</surname><given-names>AO</given-names></name><name name-style="western"><surname>Langi</surname><given-names>P</given-names></name><name name-style="western"><surname>Bakyaita</surname><given-names>N</given-names></name><name name-style="western"><surname>Egwang</surname><given-names>T</given-names></name><name name-style="western"><surname>Mutabingwa</surname><given-names>TK</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>W</given-names></name><etal/></person-group><article-title>Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: What is the relationship between these three factors?</article-title><source>Trans R Soc Trop Med Hyg</source><year>2002</year><volume>96</volume><fpage>310</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/S0035-9203(02)90108-2</pub-id><pub-id pub-id-type="pmid">12174786</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artzy-Randrup</surname><given-names>Y</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>D</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>M</given-names></name></person-group><article-title>Transmission intensity and drug resistance in malaria population dynamics: implications for climate change</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><fpage>e13588</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0013588</pub-id><pub-id pub-id-type="pmid">21060886</pub-id><pub-id pub-id-type="pmcid">PMC2965653</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>EY</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Laxminarayan</surname><given-names>R</given-names></name><name name-style="western"><surname>Levin</surname><given-names>S</given-names></name></person-group><article-title>Superinfection and the evolution of resistance to antimalarial drugs</article-title><source>Proc Biol Sci</source><year>2012</year><volume>279</volume><fpage>3834</fpage><lpage>3842</lpage><pub-id pub-id-type="doi">10.1098/rspb.2012.1064</pub-id><pub-id pub-id-type="pmid">22787024</pub-id><pub-id pub-id-type="pmcid">PMC3415915</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>GL</given-names></name><name name-style="western"><surname>Gething</surname><given-names>PW</given-names></name><name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Fidoc</surname><given-names>DA</given-names></name></person-group><article-title>Modeling within-host effects of drugs on <italic toggle="yes">Plasmodium falciparum</italic> transmission and prospects for malaria elimination</article-title><source>PLoS Comput Biol</source><year>2014</year><volume>10</volume><fpage>e1003434</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003434</pub-id><pub-id pub-id-type="pmid">24465196</pub-id><pub-id pub-id-type="pmcid">PMC3900379</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><mixed-citation publication-type="other">WHO. Malaria Vaccine Funders Group. Malaria vaccine technology roadmap. 2013. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.who.int/immunization/topics/malaria/vaccine">http://www.who.int/immunization/topics/malaria/vaccine</ext-link> roadmap/TRM update nov13.pdf of subordinate document. Accessed 6 Sept 2015.</mixed-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willyard</surname><given-names>C</given-names></name></person-group><article-title>Malaria eradication: blocking transmission to mosquitoes</article-title><source>Pharm J</source><year>2015</year><volume>294</volume><fpage>7843</fpage><lpage>7844</lpage></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>R</given-names></name></person-group><article-title>Transmission blocking malaria vaccines</article-title><source>Vaccine</source><year>2001</year><volume>19</volume><fpage>2309</fpage><lpage>2314</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(00)00521-1</pub-id><pub-id pub-id-type="pmid">11257353</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pradel</surname><given-names>G</given-names></name></person-group><article-title>Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies</article-title><source>Parasitology</source><year>2007</year><volume>134</volume><fpage>1911</fpage><lpage>1929</lpage><pub-id pub-id-type="doi">10.1017/S0031182007003381</pub-id><pub-id pub-id-type="pmid">17714601</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saxena</surname><given-names>AK</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Garboczi</surname><given-names>DN</given-names></name></person-group><article-title>Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines</article-title><source>Eukaryot Cell</source><year>2007</year><volume>6</volume><fpage>1260</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1128/EC.00060-07</pub-id><pub-id pub-id-type="pmid">17557884</pub-id><pub-id pub-id-type="pmcid">PMC1951121</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomas</surname><given-names>AM</given-names></name><name name-style="western"><surname>Margos</surname><given-names>G</given-names></name><name name-style="western"><surname>Dimopoulos</surname><given-names>G</given-names></name><name name-style="western"><surname>van Lin</surname><given-names>LH</given-names></name><name name-style="western"><surname>de Koning-Ward</surname><given-names>TF</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>R</given-names></name><etal/></person-group><article-title>P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions</article-title><source>EMBO J</source><year>2001</year><volume>20</volume><fpage>3975</fpage><lpage>3983</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.15.3975</pub-id><pub-id pub-id-type="pmid">11483501</pub-id><pub-id pub-id-type="pmcid">PMC149139</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>YL</given-names></name><name name-style="western"><surname>Hayward</surname><given-names>RE</given-names></name><name name-style="western"><surname>Langer</surname><given-names>RC</given-names></name><name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name><name name-style="western"><surname>Vinetz</surname><given-names>JM</given-names></name></person-group><article-title>Disruption of <italic toggle="yes">Plasmodium falciparum</italic> chitinase markedly impairs parasite invasion of mosquito midgut</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>4048</fpage><lpage>4054</lpage><pub-id pub-id-type="doi">10.1128/IAI.69.6.4048-4054.2001</pub-id><pub-id pub-id-type="pmid">11349075</pub-id><pub-id pub-id-type="pmcid">PMC98468</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armistead</surname><given-names>JS</given-names></name><name name-style="western"><surname>Morlais</surname><given-names>I</given-names></name><name name-style="western"><surname>Mathias</surname><given-names>DK</given-names></name><name name-style="western"><surname>Jardim</surname><given-names>JG</given-names></name><name name-style="western"><surname>Joy</surname><given-names>J</given-names></name><name name-style="western"><surname>Fridman</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of <italic toggle="yes">Plasmodium falciparum</italic> and <italic toggle="yes">Plasmodium vivax</italic> malaria</article-title><source>Infect Immun</source><year>2014</year><volume>82</volume><fpage>818</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1128/IAI.01222-13</pub-id><pub-id pub-id-type="pmid">24478095</pub-id><pub-id pub-id-type="pmcid">PMC3911399</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Churcher</surname><given-names>TS</given-names></name><name name-style="western"><surname>Dawes</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Sinden</surname><given-names>RE</given-names></name><name name-style="western"><surname>Christophides</surname><given-names>GK</given-names></name><name name-style="western"><surname>Koella</surname><given-names>JC</given-names></name><name name-style="western"><surname>Bas&#225;&#241;ez</surname><given-names>MG</given-names></name></person-group><article-title>Population biology of malaria within the mosquito: density-dependent processes and potential implications for transmission-blocking interventions</article-title><source>Malar J</source><year>2010</year><volume>9</volume><fpage>311</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-9-311</pub-id><pub-id pub-id-type="pmid">21050427</pub-id><pub-id pub-id-type="pmcid">PMC2988043</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>EP</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>R</given-names></name><name name-style="western"><surname>Pujar</surname><given-names>NS</given-names></name></person-group><source>Vaccine development and manufacturing</source><year>2015</year><publisher-loc>New York</publisher-loc><publisher-name>Wiley</publisher-name></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>RD</given-names></name><name name-style="western"><surname>Shaffer</surname><given-names>D</given-names></name><name name-style="western"><surname>Fontes</surname><given-names>E</given-names></name><name name-style="western"><surname>Malkin</surname><given-names>EM</given-names></name><name name-style="western"><surname>Mahantyet</surname><given-names>S</given-names></name><etal/></person-group><article-title>Phase 1 trial of malaria transmission blocking vaccine candidates pfs25 and pvs25 formulated with montanide isa 51</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e2636</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002636</pub-id><pub-id pub-id-type="pmid">18612426</pub-id><pub-id pub-id-type="pmcid">PMC2440546</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Epstein</surname><given-names>JE</given-names></name><name name-style="western"><surname>Richie</surname><given-names>TL</given-names></name></person-group><article-title>The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review</article-title><source>Curr Opin Infect Dis</source><year>2013</year><volume>26</volume><fpage>420</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">23982233</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QCO.0000000000000002</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seder</surname><given-names>RA</given-names></name><name name-style="western"><surname>Chang</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Enama</surname><given-names>ME</given-names></name><name name-style="western"><surname>Zephir</surname><given-names>KL</given-names></name><name name-style="western"><surname>Sarwar</surname><given-names>UN</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>IJ</given-names></name><etal/></person-group><article-title>Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine</article-title><source>Science</source><year>2013</year><volume>341</volume><fpage>1359</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1126/science.1241800</pub-id><pub-id pub-id-type="pmid">23929949</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Przysiecki</surname><given-names>C</given-names></name><name name-style="western"><surname>Flanagan</surname><given-names>E</given-names></name><name name-style="western"><surname>Bello-Irizarry</surname><given-names>SN</given-names></name><name name-style="western"><surname>Ionescu</surname><given-names>R</given-names></name><name name-style="western"><surname>Muratova</surname><given-names>O</given-names></name><etal/></person-group><article-title>Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>18243</fpage><lpage>18248</lpage><pub-id pub-id-type="doi">10.1073/pnas.0608545103</pub-id><pub-id pub-id-type="pmid">17110440</pub-id><pub-id pub-id-type="pmcid">PMC1636993</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheru</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Diouf</surname><given-names>A</given-names></name><name name-style="western"><surname>Moretz</surname><given-names>SE</given-names></name><name name-style="western"><surname>Muratova</surname><given-names>OV</given-names></name><name name-style="western"><surname>Song</surname><given-names>G</given-names></name><etal/></person-group><article-title>The IC50 of anti-Pfs25 antibody in membrane feeding assay varies among species</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>4423</fpage><lpage>4429</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2010.04.036</pub-id><pub-id pub-id-type="pmid">20434549</pub-id><pub-id pub-id-type="pmcid">PMC2880321</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Angov</surname><given-names>E</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name></person-group><article-title>Potent Malaria transmission-blocking antibody responses elicited by <italic toggle="yes">Plasmodium falciparum</italic> Pfs25 expressed in <italic toggle="yes">Escherichia coli</italic> after successful protein refolding</article-title><source>Infect Immun</source><year>2014</year><volume>82</volume><fpage>1453</fpage><lpage>1459</lpage><pub-id pub-id-type="doi">10.1128/IAI.01438-13</pub-id><pub-id pub-id-type="pmid">24421036</pub-id><pub-id pub-id-type="pmcid">PMC3993404</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theisen</surname><given-names>M</given-names></name><name name-style="western"><surname>Roeffen</surname><given-names>W</given-names></name><name name-style="western"><surname>Singh</surname><given-names>SK</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>G</given-names></name><name name-style="western"><surname>Amoah</surname><given-names>L</given-names></name><name name-style="western"><surname>van de Vegte-Bolmer</surname><given-names>M</given-names></name><etal/></person-group><article-title>A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>2623</fpage><lpage>2630</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.03.020</pub-id><pub-id pub-id-type="pmid">24662702</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kocken</surname><given-names>CH</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>J</given-names></name><name name-style="western"><surname>Kaan</surname><given-names>AM</given-names></name><name name-style="western"><surname>Beckers</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Ponnudurai</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaslow</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of <italic toggle="yes">Plasmodium falciparum</italic></article-title><source>Mol Biochem Parasitol</source><year>1993</year><volume>61</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/0166-6851(93)90158-T</pub-id><pub-id pub-id-type="pmid">8259133</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaslow</surname><given-names>DC</given-names></name><name name-style="western"><surname>Bathurst</surname><given-names>IC</given-names></name><name name-style="western"><surname>Lensen</surname><given-names>T</given-names></name><name name-style="western"><surname>Ponnudurai</surname><given-names>T</given-names></name><name name-style="western"><surname>Barr</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Keister</surname><given-names>DB</given-names></name></person-group><article-title>Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of <italic toggle="yes">Plasmodium falciparum</italic></article-title><source>Infect Immun</source><year>1994</year><volume>62</volume><fpage>5576</fpage><lpage>5580</lpage><pub-id pub-id-type="pmid">7960139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.62.12.5576-5580.1994</pub-id><pub-id pub-id-type="pmcid">PMC303304</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>L</given-names></name><name name-style="western"><surname>Miles</surname><given-names>AP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Stowers</surname><given-names>AW</given-names></name></person-group><article-title>Expression of malaria transmission-blocking vaccine antigen Pfs25 in <italic toggle="yes">Pichia pastoris</italic> for use in human clinical trials</article-title><source>Vaccine</source><year>2003</year><volume>21</volume><fpage>1650</fpage><lpage>1657</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(02)00701-6</pub-id><pub-id pub-id-type="pmid">12639486</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>RM</given-names></name><name name-style="western"><surname>Chichester</surname><given-names>JA</given-names></name><name name-style="western"><surname>Mett</surname><given-names>V</given-names></name><name name-style="western"><surname>Jaje</surname><given-names>J</given-names></name><name name-style="western"><surname>Tottey</surname><given-names>S</given-names></name><name name-style="western"><surname>Manceva</surname><given-names>S</given-names></name><etal/></person-group><article-title>A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against <italic toggle="yes">Plasmodium falciparum</italic> in immunized mice</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e79538</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0079538</pub-id><pub-id pub-id-type="pmid">24260245</pub-id><pub-id pub-id-type="pmcid">PMC3832600</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gregory</surname><given-names>JA</given-names></name><name name-style="western"><surname>Mayfield</surname><given-names>SP</given-names></name></person-group><article-title>Developing inexpensive malaria vaccines from plants and algae</article-title><source>Appl Microbiol Biotechnol</source><year>2014</year><volume>98</volume><fpage>1983</fpage><lpage>1990</lpage><pub-id pub-id-type="doi">10.1007/s00253-013-5477-6</pub-id><pub-id pub-id-type="pmid">24413920</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherif</surname><given-names>MS</given-names></name><name name-style="western"><surname>Shuaibu</surname><given-names>MN</given-names></name><name name-style="western"><surname>Kodama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kurosaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Helegbe</surname><given-names>GK</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in <italic toggle="yes">Plasmodium yoelii</italic> malaria model</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>1998</fpage><lpage>2006</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.01.005</pub-id><pub-id pub-id-type="pmid">24440206</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferraro</surname><given-names>B</given-names></name><name name-style="western"><surname>Talbott</surname><given-names>KT</given-names></name><name name-style="western"><surname>Balakrishnan</surname><given-names>A</given-names></name><name name-style="western"><surname>Cisper</surname><given-names>N</given-names></name><name name-style="western"><surname>Morrow</surname><given-names>MP</given-names></name><name name-style="western"><surname>Hutnick</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA</article-title><source>Infect Immun</source><year>2013</year><volume>81</volume><fpage>3709</fpage><lpage>3720</lpage><pub-id pub-id-type="doi">10.1128/IAI.00180-13</pub-id><pub-id pub-id-type="pmid">23897618</pub-id><pub-id pub-id-type="pmcid">PMC3811783</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kongkasuriyachai</surname><given-names>D</given-names></name><name name-style="western"><surname>Bartels-Andrews</surname><given-names>L</given-names></name><name name-style="western"><surname>Stowers</surname><given-names>A</given-names></name><name name-style="western"><surname>Collins</surname><given-names>WE</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>J</given-names></name><name name-style="western"><surname>Sattabongkot</surname><given-names>J</given-names></name><etal/></person-group><article-title>Potent immunogenicity of DNA vaccines encoding <italic toggle="yes">Plasmodium vivax</italic> transmission-blocking vaccine candidates Pvs25 and Pvs28&#8212;evaluation of homologous and heterologous antigen-delivery prime-boost strategy</article-title><source>Vaccine</source><year>2004</year><volume>22</volume><fpage>3205</fpage><lpage>3213</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2003.11.060</pub-id><pub-id pub-id-type="pmid">15297075</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name></person-group><article-title>DNA-based vaccines against malaria: status and promise of the multi-stage malaria DNA vaccine operation</article-title><source>Int J Parasitol</source><year>2001</year><volume>31</volume><fpage>753</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/S0020-7519(01)00184-9</pub-id><pub-id pub-id-type="pmid">11403765</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikolaeva</surname><given-names>D</given-names></name><name name-style="western"><surname>Draper</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>S</given-names></name></person-group><article-title>Toward the development of effective transmission blocking vaccines for malaria</article-title><source>Expert Rev Vaccines</source><year>2015</year><volume>14</volume><fpage>653</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1586/14760584.2015.993383</pub-id><pub-id pub-id-type="pmid">25597923</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wells</surname><given-names>TN</given-names></name><name name-style="western"><surname>Burrows</surname><given-names>JN</given-names></name><name name-style="western"><surname>Baird</surname><given-names>JK</given-names></name></person-group><article-title>Targeting the hypnozoite reservoir of <italic toggle="yes">Plasmodium vivax</italic>: the hidden obstacle to malaria elimination</article-title><source>Trends Parasitol</source><year>2010</year><volume>26</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2009.12.005</pub-id><pub-id pub-id-type="pmid">20133198</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><mixed-citation publication-type="other">Clinical trials&#8212;U.S. National Institutes of Health. Testing Pfs25-EPA/Alhydrogel as a potential malaria transmission blocking vaccine. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01867463">https://clinicaltrials.gov/ct2/show/NCT01867463</ext-link>. Accessed 19 Sept 2015.</mixed-citation></ref><ref id="CR152"><label>152.</label><mixed-citation publication-type="other">Clinical trials&#8212;U.S. National Institutes of Health. Safety and immunogenicity of plant-derived Pfs25 VLP-FhCMB malaria transmission blocking vaccine in healthy adults <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02013687">https://clinicaltrials.gov/ct2/show/NCT02013687</ext-link>. Accessed 19 Sept 2015.</mixed-citation></ref><ref id="CR153"><label>153.</label><mixed-citation publication-type="other">WHO. Global malaria vaccine pipeline. World Health Oganization, Geneva. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.who.int/vaccine_research/links/Rainbow/en/index.html">http://www.who.int/vaccine_research/links/Rainbow/en/index.html</ext-link>. Accessed 1 Feb 2016.</mixed-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubler-Kielb</surname><given-names>J</given-names></name><name name-style="western"><surname>Majadly</surname><given-names>F</given-names></name><name name-style="western"><surname>Biesova</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mocca</surname><given-names>CP</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>R</given-names></name><etal/></person-group><article-title>A bicomponent <italic toggle="yes">Plasmodium falciparum</italic> investigational vaccine composed of protein-peptide conjugates</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>1172</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1073/pnas.0913374107</pub-id><pub-id pub-id-type="pmid">20080619</pub-id><pub-id pub-id-type="pmcid">PMC2824317</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theisen</surname><given-names>M</given-names></name><name name-style="western"><surname>Roeffen</surname><given-names>W</given-names></name><name name-style="western"><surname>Singh</surname><given-names>SK</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>G</given-names></name><name name-style="western"><surname>Amoah</surname><given-names>L</given-names></name><name name-style="western"><surname>van de Vegte-Bolmer</surname><given-names>M</given-names></name><etal/></person-group><article-title>A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>2623</fpage><lpage>2630</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.03.020</pub-id><pub-id pub-id-type="pmid">24662702</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>TA</given-names></name><name name-style="western"><surname>Chitnis</surname><given-names>N</given-names></name><name name-style="western"><surname>Bri&#235;t</surname><given-names>OJ</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>M</given-names></name></person-group><article-title>Uses of mosquito-stage transmission-blocking vaccines against <italic toggle="yes">Plasmodium falciparum</italic></article-title><source>Trends Parasitol</source><year>2011</year><volume>27</volume><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2010.12.011</pub-id><pub-id pub-id-type="pmid">21277257</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunes</surname><given-names>JK</given-names></name><name name-style="western"><surname>Woods</surname><given-names>C</given-names></name><name name-style="western"><surname>Carter</surname><given-names>T</given-names></name><name name-style="western"><surname>Raphael</surname><given-names>T</given-names></name><name name-style="western"><surname>Morin</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Diallo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward</article-title><source>Vaccine</source><year>2014</year><volume>32</volume><fpage>5531</fpage><lpage>5539</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2014.07.030</pub-id><pub-id pub-id-type="pmid">25077422</pub-id></element-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu&#237;sa</surname><given-names>RC</given-names></name><name name-style="western"><surname>Hendrickx</surname><given-names>K</given-names></name></person-group><article-title>Winged promises: exploring the discourse on transgenic mosquitoes in Brazil</article-title><source>Technol Soc</source><year>2013</year><volume>35</volume><fpage>118</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/j.techsoc.2013.01.006</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Jacobs-Lorena</surname><given-names>M</given-names></name></person-group><article-title>Genetic approaches to interfere with malaria transmission by vector mosquitoes</article-title><source>Trends Biotechnol</source><year>2013</year><volume>31</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2013.01.001</pub-id><pub-id pub-id-type="pmid">23395485</pub-id><pub-id pub-id-type="pmcid">PMC3593784</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Powell</surname><given-names>JR</given-names></name><name name-style="western"><surname>Tabachnick</surname><given-names>WJ</given-names></name></person-group><article-title>Genetic shifting: a novel approach for controlling vector-borne diseases</article-title><source>Trends Parasitol</source><year>2014</year><volume>30</volume><fpage>282</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2014.04.005</pub-id><pub-id pub-id-type="pmid">24794113</pub-id><pub-id pub-id-type="pmcid">PMC4078766</pub-id></element-citation></ref><ref id="CR161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alphey</surname><given-names>L</given-names></name></person-group><article-title>Genetic control of mosquitoes</article-title><source>Annu Rev Entomol</source><year>2014</year><volume>59</volume><fpage>205</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1146/annurev-ento-011613-162002</pub-id><pub-id pub-id-type="pmid">24160434</pub-id></element-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zieler</surname><given-names>H</given-names></name><name name-style="western"><surname>Keister</surname><given-names>DB</given-names></name><name name-style="western"><surname>Dvorak</surname><given-names>JA</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>JM</given-names></name></person-group><article-title>A snake venom phospholipase A(2) blocks malaria parasite development in the mosquito midgut by inhibiting ookinete association with the midgut surface</article-title><source>J Exp Biol</source><year>2001</year><volume>204</volume><fpage>4157</fpage><lpage>4167</lpage><pub-id pub-id-type="pmid">11809789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/jeb.204.23.4157</pub-id></element-citation></ref><ref id="CR163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>J</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>A</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>LA</given-names></name><name name-style="western"><surname>Wimmer</surname><given-names>EA</given-names></name><name name-style="western"><surname>Jacobs-Lorena</surname><given-names>M</given-names></name></person-group><article-title>Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite</article-title><source>Nature</source><year>2002</year><volume>417</volume><fpage>452</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1038/417452a</pub-id><pub-id pub-id-type="pmid">12024215</pub-id></element-citation></ref><ref id="CR164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knols</surname><given-names>BG</given-names></name><name name-style="western"><surname>Bossin</surname><given-names>HC</given-names></name><name name-style="western"><surname>Mukabana</surname><given-names>WR</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>AS</given-names></name></person-group><article-title>Transgenic mosquitoes and the fight against malaria: managing technology push in a turbulent GMO world</article-title><source>Am J Trop Med Hyg</source><year>2007</year><volume>77</volume><fpage>232</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">18165498</pub-id></element-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bo&#235;te</surname><given-names>C</given-names></name><name name-style="western"><surname>Agusto</surname><given-names>FB</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>RG</given-names></name></person-group><article-title>Impact of mating behaviour on the success of malaria control through a single inundative release of transgenic mosquitoes</article-title><source>J Theor Biol</source><year>2014</year><volume>347</volume><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2014.01.010</pub-id><pub-id pub-id-type="pmid">24440174</pub-id></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Windbichler</surname><given-names>N</given-names></name><name name-style="western"><surname>Menichelli</surname><given-names>M</given-names></name><name name-style="western"><surname>Papathanos</surname><given-names>PA</given-names></name><name name-style="western"><surname>Thyme</surname><given-names>SB</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Ulge</surname><given-names>UY</given-names></name><etal/></person-group><article-title>A synthetic homing endonuclease-based gene drive system in the human malaria mosquito</article-title><source>Nature</source><year>2011</year><volume>473</volume><fpage>212</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/nature09937</pub-id><pub-id pub-id-type="pmid">21508956</pub-id><pub-id pub-id-type="pmcid">PMC3093433</pub-id></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gantza</surname><given-names>VM</given-names></name><name name-style="western"><surname>Jasinskiene</surname><given-names>N</given-names></name><name name-style="western"><surname>Tatarenkova</surname><given-names>O</given-names></name><name name-style="western"><surname>Fazekas</surname><given-names>A</given-names></name><name name-style="western"><surname>Macias</surname><given-names>VM</given-names></name><name name-style="western"><surname>Bier</surname><given-names>E</given-names></name><etal/></person-group><article-title>Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito <italic toggle="yes">Anopheles stephensi</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2015</year><volume>112</volume><fpage>6736</fpage><lpage>6743</lpage><pub-id pub-id-type="doi">10.1073/pnas.1521077112</pub-id><pub-id pub-id-type="pmid">26598698</pub-id><pub-id pub-id-type="pmcid">PMC4679060</pub-id></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kistler</surname><given-names>KE</given-names></name><name name-style="western"><surname>Vosshall</surname><given-names>LB</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>BJ</given-names></name></person-group><article-title>Genome engineering with CRISPR-Cas9 in the mosquito <italic toggle="yes">Aedes aegypti</italic></article-title><source>Cell Rep</source><year>2015</year><volume>11</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.009</pub-id><pub-id pub-id-type="pmid">25818303</pub-id><pub-id pub-id-type="pmcid">PMC4394034</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hammond</surname><given-names>A</given-names></name><name name-style="western"><surname>Galizi</surname><given-names>R</given-names></name><name name-style="western"><surname>Kyrou</surname><given-names>K</given-names></name><name name-style="western"><surname>Simoni</surname><given-names>A</given-names></name><name name-style="western"><surname>Siniscalchi</surname><given-names>C</given-names></name><name name-style="western"><surname>Katsanos</surname><given-names>D</given-names></name><etal/></person-group><article-title>A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector <italic toggle="yes">Anopheles gambiae</italic></article-title><source>Nat Biotechnol</source><year>2016</year><volume>34</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/nbt.3439</pub-id><pub-id pub-id-type="pmid">26641531</pub-id><pub-id pub-id-type="pmcid">PMC4913862</pub-id></element-citation></ref><ref id="CR170"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durvasula</surname><given-names>RV</given-names></name><name name-style="western"><surname>Gumbs</surname><given-names>A</given-names></name><name name-style="western"><surname>Panackal</surname><given-names>A</given-names></name><name name-style="western"><surname>Kruglov</surname><given-names>O</given-names></name><name name-style="western"><surname>Aksoy</surname><given-names>S</given-names></name><name name-style="western"><surname>Merrifield</surname><given-names>RB</given-names></name><etal/></person-group><article-title>Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria</article-title><source>Proc Natl Acad Sci U S A</source><year>1997</year><volume>94</volume><fpage>3274</fpage><lpage>3278</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.7.3274</pub-id><pub-id pub-id-type="pmid">9096383</pub-id><pub-id pub-id-type="pmcid">PMC20359</pub-id></element-citation></ref><ref id="CR171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riehle</surname><given-names>MA</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>CK</given-names></name><name name-style="western"><surname>Lampe</surname><given-names>D</given-names></name><name name-style="western"><surname>Lauzon</surname><given-names>C</given-names></name><name name-style="western"><surname>Jacobs-Lorena</surname><given-names>M</given-names></name></person-group><article-title>Using bacteria to express and display anti-Plasmodium molecules in the mosquito midgut</article-title><source>Int J Parasitol</source><year>2007</year><volume>37</volume><fpage>595</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2006.12.002</pub-id><pub-id pub-id-type="pmid">17224154</pub-id></element-citation></ref><ref id="CR172"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Bongio</surname><given-names>N</given-names></name><name name-style="western"><surname>Stebbings</surname><given-names>KA</given-names></name><name name-style="western"><surname>Lampe</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Jacobs-Lorena</surname><given-names>M</given-names></name></person-group><article-title>Fighting malaria with engineered symbiotic bacteria from vector mosquitoes</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><fpage>12734</fpage><lpage>12739</lpage><pub-id pub-id-type="doi">10.1073/pnas.1204158109</pub-id><pub-id pub-id-type="pmid">22802646</pub-id><pub-id pub-id-type="pmcid">PMC3412027</pub-id></element-citation></ref><ref id="CR173"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>X</given-names></name><name name-style="western"><surname>Hoiczyk</surname><given-names>E</given-names></name><name name-style="western"><surname>Rasgon</surname><given-names>JL</given-names></name></person-group><article-title>Viral paratransgenesis in the malaria vector <italic toggle="yes">Anopheles gambiae</italic></article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000135</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000135</pub-id><pub-id pub-id-type="pmid">18725926</pub-id><pub-id pub-id-type="pmcid">PMC2500179</pub-id></element-citation></ref><ref id="CR174"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Straif</surname><given-names>SC</given-names></name><name name-style="western"><surname>Mbogo</surname><given-names>CN</given-names></name><name name-style="western"><surname>Toure</surname><given-names>AM</given-names></name><name name-style="western"><surname>Walker</surname><given-names>ED</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>M</given-names></name><name name-style="western"><surname>Toure</surname><given-names>YT</given-names></name><etal/></person-group><article-title>Midgut bacteria in <italic toggle="yes">Anopheles gambiae</italic> and <italic toggle="yes">An. funestus</italic> (Diptera: Culicidae) from Kenya and Mali</article-title><source>J Med Entomol</source><year>1998</year><volume>35</volume><fpage>222</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1093/jmedent/35.3.222</pub-id><pub-id pub-id-type="pmid">9615538</pub-id></element-citation></ref><ref id="CR175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>S</given-names></name><name name-style="western"><surname>Ioka</surname><given-names>D</given-names></name><name name-style="western"><surname>Matsuoka</surname><given-names>H</given-names></name><name name-style="western"><surname>Endo</surname><given-names>H</given-names></name><name name-style="western"><surname>Ishii</surname><given-names>A</given-names></name></person-group><article-title>Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes</article-title><source>Mol Biochem Parasitol</source><year>2001</year><volume>113</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/S0166-6851(00)00387-X</pub-id><pub-id pub-id-type="pmid">11254957</pub-id></element-citation></ref><ref id="CR176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>T</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>LA</given-names></name></person-group><article-title>Can Wolbachia be used to control malaria?</article-title><source>Mem Inst Oswaldo Cruz</source><year>2011</year><volume>106</volume><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762011000900026</pub-id><pub-id pub-id-type="pmid">21881776</pub-id></element-citation></ref><ref id="CR177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>W</given-names></name><name name-style="western"><surname>Vega-Rodr&#237;guez</surname><given-names>J</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Jacobs-Lorena</surname><given-names>M</given-names></name><name name-style="western"><surname>Kang</surname><given-names>A</given-names></name><name name-style="western"><surname>St Leger</surname><given-names>RJ</given-names></name></person-group><article-title>Development of transgenic fungi that kill human malaria parasites in mosquitoes</article-title><source>Science</source><year>2011</year><volume>331</volume><fpage>1074</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1126/science.1199115</pub-id><pub-id pub-id-type="pmid">21350178</pub-id><pub-id pub-id-type="pmcid">PMC4153607</pub-id></element-citation></ref><ref id="CR178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Konrad</surname><given-names>BP</given-names></name><name name-style="western"><surname>Lindstrom</surname><given-names>M</given-names></name><name name-style="western"><surname>Gumpinger</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Coombs</surname><given-names>D</given-names></name></person-group><article-title>Assessing the optimal virulence of malaria-targeting mosquito pathogens: a mathematical study of engineered <italic toggle="yes">Metarhizium anisopliae</italic></article-title><source>Malar J</source><year>2014</year><volume>13</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-13-11</pub-id><pub-id pub-id-type="pmid">24397503</pub-id><pub-id pub-id-type="pmcid">PMC3893513</pub-id></element-citation></ref><ref id="CR179"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delrieu</surname><given-names>I</given-names></name><name name-style="western"><surname>Leboulleux</surname><given-names>D</given-names></name><name name-style="western"><surname>Ivinson</surname><given-names>K</given-names></name><name name-style="western"><surname>Gessner</surname><given-names>BD</given-names></name><collab>Malaria Transmission Blocking Vaccine Technical Consultation Group</collab></person-group><article-title>Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><fpage>1518</fpage><lpage>1526</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2015.01.050</pub-id><pub-id pub-id-type="pmid">25681064</pub-id></element-citation></ref><ref id="CR180"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>MalERA Consultative Group on Modeling</collab></person-group><article-title>A research agenda for malaria eradication: modeling</article-title><source>PLoS Med</source><year>2011</year><volume>8</volume><fpage>e1000403</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1000403</pub-id><pub-id pub-id-type="pmid">21283605</pub-id><pub-id pub-id-type="pmcid">PMC3026697</pub-id></element-citation></ref><ref id="CR181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Maude</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Pongtavornpinyo</surname><given-names>W</given-names></name><name name-style="western"><surname>Saralamba</surname><given-names>S</given-names></name><name name-style="western"><surname>Aguas</surname><given-names>R</given-names></name><name name-style="western"><surname>Van Effelterre</surname><given-names>T</given-names></name><etal/></person-group><article-title>The role of simple mathematical models in malaria elimination strategy design</article-title><source>Malar J</source><year>2009</year><volume>8</volume><fpage>212</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-8-212</pub-id><pub-id pub-id-type="pmid">19747403</pub-id><pub-id pub-id-type="pmcid">PMC2754494</pub-id></element-citation></ref><ref id="CR182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffin</surname><given-names>JT</given-names></name><name name-style="western"><surname>Hollingsworth</surname><given-names>TD</given-names></name><name name-style="western"><surname>Okell</surname><given-names>LC</given-names></name><name name-style="western"><surname>Churcher</surname><given-names>TS</given-names></name><name name-style="western"><surname>White</surname><given-names>M</given-names></name><name name-style="western"><surname>Hinsley</surname><given-names>W</given-names></name><etal/></person-group><article-title>Reducing <italic toggle="yes">Plasmodium falciparum</italic> malaria transmission in africa: a model-based evaluation of intervention strategies</article-title><source>PLoS Med</source><year>2010</year><volume>7</volume><fpage>e1000324</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1000324</pub-id><pub-id pub-id-type="pmid">20711482</pub-id><pub-id pub-id-type="pmcid">PMC2919425</pub-id></element-citation></ref><ref id="CR183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Najera</surname><given-names>J&#193;</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Silva</surname><given-names>M</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>PL</given-names></name></person-group><article-title>Some lessons for the future from the global malaria eradication programme (1955&#8211;1969)</article-title><source>PLoS Med</source><year>2011</year><volume>8</volume><fpage>e1000412</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1000412</pub-id><pub-id pub-id-type="pmid">21311585</pub-id><pub-id pub-id-type="pmcid">PMC3026700</pub-id></element-citation></ref><ref id="CR184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>JM</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Cotter</surname><given-names>C</given-names></name><name name-style="western"><surname>Ward</surname><given-names>A</given-names></name><name name-style="western"><surname>Yamey</surname><given-names>G</given-names></name><name name-style="western"><surname>Sabot</surname><given-names>OJ</given-names></name><etal/></person-group><article-title>Malaria resurgence: a systematic review and assessment of its causes</article-title><source>Malar J</source><year>2012</year><volume>11</volume><fpage>122</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-11-122</pub-id><pub-id pub-id-type="pmid">22531245</pub-id><pub-id pub-id-type="pmcid">PMC3458906</pub-id></element-citation></ref><ref id="CR185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artzy-Randrup</surname><given-names>Y</given-names></name><name name-style="western"><surname>Andrew</surname><given-names>P</given-names></name><name name-style="western"><surname>Dobsond</surname><given-names>AP</given-names></name><name name-style="western"><surname>Pascua</surname><given-names>M</given-names></name></person-group><article-title>Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria</article-title><source>Proc Natl Acad Sci U S A</source><year>2015</year><volume>112</volume><fpage>3014</fpage><lpage>3019</lpage><pub-id pub-id-type="doi">10.1073/pnas.1409467112</pub-id><pub-id pub-id-type="pmid">25605894</pub-id><pub-id pub-id-type="pmcid">PMC4364214</pub-id></element-citation></ref><ref id="CR186"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Gething</surname><given-names>PW</given-names></name><name name-style="western"><surname>Kabaria</surname><given-names>CW</given-names></name><name name-style="western"><surname>Snow</surname><given-names>RW</given-names></name><name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name></person-group><article-title>Ranking of elimination feasibility between malaria-endemic countries</article-title><source>Lancet</source><year>2010</year><volume>376</volume><fpage>1579</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61301-3</pub-id><pub-id pub-id-type="pmid">21035838</pub-id><pub-id pub-id-type="pmcid">PMC3044847</pub-id></element-citation></ref><ref id="CR187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>A</given-names></name><name name-style="western"><surname>Lubell</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hanson</surname><given-names>K</given-names></name></person-group><article-title>Malaria eradication: the economic, financial and institutional challenge</article-title><source>Malar J</source><year>2008</year><volume>7</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-7-S1-S11</pub-id><pub-id pub-id-type="pmid">19091035</pub-id><pub-id pub-id-type="pmcid">PMC2604875</pub-id></element-citation></ref><ref id="CR188"><label>188.</label><mixed-citation publication-type="other">WHO. Use of MenAfriVac&#8482; (meningitis A vaccine) in a controlled temperature chain(CTC) during campaigns. 2013. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.who.int/immunization/documents/WHO_IVB_13.04_5_6/en/">www.who.int/immunization/documents/WHO_IVB_13.04_5_6/en/</ext-link> Accessed 20 Sept 2015.</mixed-citation></ref><ref id="CR189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>RTS,S Clinical Trials Partnership</collab></person-group><article-title>Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial</article-title><source>Lancet</source><year>2015</year><volume>2015</volume><issue>386</issue><fpage>31</fpage><lpage>45</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(15)60721-8</pub-id><pub-id pub-id-type="pmcid">PMC5626001</pub-id><pub-id pub-id-type="pmid">25913272</pub-id></element-citation></ref><ref id="CR190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penny</surname><given-names>MA</given-names></name><name name-style="western"><surname>Verity</surname><given-names>R</given-names></name><name name-style="western"><surname>Bever</surname><given-names>CA</given-names></name><name name-style="western"><surname>Sauboin</surname><given-names>C</given-names></name><name name-style="western"><surname>Galactionova</surname><given-names>K</given-names></name><name name-style="western"><surname>Flasche</surname><given-names>S</given-names></name><etal/></person-group><article-title>Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models</article-title><source>Lancet</source><year>2016</year><volume>387</volume><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)00725-4</pub-id><pub-id pub-id-type="pmid">26549466</pub-id><pub-id pub-id-type="pmcid">PMC4723722</pub-id></element-citation></ref><ref id="CR191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reeves</surname><given-names>RG</given-names></name><name name-style="western"><surname>Denton</surname><given-names>JA</given-names></name><name name-style="western"><surname>Santucci</surname><given-names>F</given-names></name><name name-style="western"><surname>Bryk</surname><given-names>J</given-names></name><name name-style="western"><surname>Reed</surname><given-names>FA</given-names></name></person-group><article-title>Scientific standards and the regulation of genetically modified insects</article-title><source>PLoS Negl Trop Dis</source><year>2012</year><volume>6</volume><fpage>e1502</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0001502</pub-id><pub-id pub-id-type="pmid">22319640</pub-id><pub-id pub-id-type="pmcid">PMC3269433</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>